{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:47:27Z","timestamp":1791823647305,"version":"4.3.4"},"reference-count":239,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"DOI":"10.1007\/s11427-026-3436-8","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:02:02Z","timestamp":1791770522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammation as a central driver in AML pathogenesis and therapy resistance"],"prefix":"10.1007","author":[{"given":"Hanxi","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"3436_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s40001-025-02879-8","volume":"30","author":"DA Abdelhady","year":"2025","unstructured":"Abdelhady, D.A., Azab, M.M.M., Alnagar, A.A., and Said, N. (2025). Effect of vitamin D status on a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 (ADAMTS13) and interleukin 6 in patients with acute myeloid leukaemia. Eur J Med Res 30, 637.","journal-title":"Eur J Med Res"},{"key":"3436_CR2","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1038\/s41388-018-0151-1","volume":"37","author":"AM Abdul-Aziz","year":"2018","unstructured":"Abdul-Aziz, A.M., Shafat, M.S., Sun, Y., Marlein, C.R., Piddock, R.E., Robinson, S.D., Edwards, D.R., Zhou, Z., Collins, A., Bowles, K.M., et al. (2018). HIF1\u03b1 drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia. Oncogene 37, 2676\u20132686.","journal-title":"Oncogene"},{"key":"3436_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.exphem.2017.11.002","volume":"59","author":"SO Abegunde","year":"2018","unstructured":"Abegunde, S.O., Buckstein, R., Wells, R.A., and Rauh, M.J. (2018). An inflammatory environment containing TNF\u03b1 favors Tet2-mutant clonal hematopoiesis. Exp Hematol 59, 60\u201365.","journal-title":"Exp Hematol"},{"key":"3436_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","volume":"559","author":"S Abelson","year":"2018","unstructured":"Abelson, S., Collord, G., Ng, S.W.K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P.C., Heisler, L., Sundaravadanam, Y., et al. (2018). Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559, 400\u2013404.","journal-title":"Nature"},{"key":"3436_CR5","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/cam4.4661","volume":"11","author":"M Abolhalaj","year":"2022","unstructured":"Abolhalaj, M., Sincic, V., Lilljebj\u00f6rn, H., Sand\u00e9n, C., Aab, A., H\u00e4gerbrand, K., Ellmark, P., Borrebaeck, C.A.K., Fioretos, T., and Lundberg, K. (2022). Transcriptional profiling demonstrates altered characteristics of CD8+ cytotoxic T-cells and regulatory T-cells in TP53-mutated acute myeloid leukemia. Cancer Med 11, 3023\u20133032.","journal-title":"Cancer Med"},{"key":"3436_CR6","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12032-013-0732-3","volume":"30","author":"NK Abousamra","year":"2013","unstructured":"Abousamra, N.K., Salah El-Din, M., and Helal, R. (2013). Prognostic value of Th17 cells in acute leukemia. Med Oncol 30, 732.","journal-title":"Med Oncol"},{"key":"3436_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s44161-023-00322-x","volume":"2","author":"WT Abplanalp","year":"2023","unstructured":"Abplanalp, W.T., Schuhmacher, B., Cremer, S., Merten, M., Shumliakivska, M., Macinkovic, I., Zeiher, A.M., John, D., and Dimmeler, S. (2023). Cell-intrinsic effects of clonal hematopoiesis in heart failure. Nat Cardiovasc Res 2, 819\u2013834.","journal-title":"Nat Cardiovasc Res"},{"key":"3436_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.biopha.2017.10.100","volume":"97","author":"DO Acheampong","year":"2018","unstructured":"Acheampong, D.O., Adokoh, C.K., Asante, D.B., Asiamah, E.A., Barnie, P.A., Bonsu, D.O.M., and Kyei, F. (2018). Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy. Biomed Pharmacother 97, 225\u2013232.","journal-title":"Biomed Pharmacother"},{"key":"3436_CR9","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.3390\/ijms23116260","volume":"23","author":"AF AlAsmari","year":"2022","unstructured":"AlAsmari, A.F., Alghamdi, A., Ali, N., Almeaikl, M.A., Hakami, H.M., Alyousef, M.K., AlSwayyed, M., Alharbi, M., Alqahtani, F., Alasmari, F., et al. (2022). Venetoclax induces cardiotoxicity through modulation of oxidative-stress-mediated cardiac inflammation and apoptosis via NF-\u03baB and BCL-2 pathway. Int J Mol Sci 23, 6260.","journal-title":"Int J Mol Sci"},{"key":"3436_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/14737140.2025.2483855","volume":"25","author":"A Alhajahjeh","year":"2025","unstructured":"Alhajahjeh, A., Stahl, M., Kim, T.K., Kewan, T., Stempel, J.M., Zeidan, A.M., and Bewersdorf, J.P. (2025). Contemporary understanding of myeloid-derived suppressor cells in the acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) tumor microenvironment. Expert Rev Anticancer Ther 25, 435\u2013456.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3436_CR11","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1182\/blood.2024028239","volume":"145","author":"B Allen","year":"2025","unstructured":"Allen, B., Bottomly, D., K\u00f6hnke, T., Wang, A., Lin, H.Y., Johnson, K., Kenna, I., Streltsova, A., Martin, E., Chen, R., et al. (2025). A CEBPB\/IL-1\u03b2\/TNF-\u03b1 feedback loop drives drug resistance to venetoclax and MDM2 inhibitors in monocytic leukemia. Blood 145, 2488\u20132506.","journal-title":"Blood"},{"key":"3436_CR12","doi-asserted-by":"publisher","first-page":"152347","DOI":"10.1016\/j.seminoncol.2025.152347","volume":"52","author":"AA Angelo","year":"2025","unstructured":"Angelo, A.A., Adane, G., Berta, D.M., Elias Chane, D.M., Cherie, N., Tamir, M., and Teketelew, B.B. (2025). The dual effect of interferon-\u03b3 in acute myeloid leukemia: a narrative review. Semin Oncol 52, 152347.","journal-title":"Semin Oncol"},{"key":"3436_CR13","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber, D.A., Orazi, A., Hasserjian, R.P., Borowitz, M.J., Calvo, K.R., Kvasnicka, H.M., Wang, S.A., Bagg, A., Barbui, T., Branford, S., et al. (2022). International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140, 1200\u20131228.","journal-title":"Blood"},{"key":"3436_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nature13383","volume":"512","author":"L Arranz","year":"2014","unstructured":"Arranz, L., S\u00e1nchez-Aguilera, A., Mart\u00edn-P\u00e9rez, D., Isern, J., Langa, X., Tzankov, A., Lundberg, P., Munti\u00f3n, S., Tzeng, Y.S., Lai, D.M., et al. (2014). Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms. Nature 512, 78\u201381.","journal-title":"Nature"},{"key":"3436_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0925-5710(97)00070-4","volume":"66","author":"Y Asano","year":"1997","unstructured":"Asano, Y., Shibata, S., Kobayashi, S., Okamura, S., and Niho, Y. (1997). Interleukin-10 inhibits the autocrine growth of leukemic blast cells from patients with acute myeloblastic leukemia. Int J Hematol 66, 445.","journal-title":"Int J Hematol"},{"key":"3436_CR16","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.3390\/cancers13246246","volume":"13","author":"A Aureli","year":"2021","unstructured":"Aureli, A., Marziani, B., Sconocchia, T., Del Principe, M.I., Buzzatti, E., Pasqualone, G., Venditti, A., and Sconocchia, G. (2021). Immunotherapy as a turning point in the treatment of acute myeloid leukemia. Cancers 13, 6246.","journal-title":"Cancers"},{"key":"3436_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.aba9304","volume":"374","author":"S Avagyan","year":"2021","unstructured":"Avagyan, S., Henninger, J.E., Mannherz, W.P., Mistry, M., Yoon, J., Yang, S., Weber, M.C., Moore, J.L., and Zon, L.I. (2021). Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis. Science 374, 768\u2013772.","journal-title":"Science"},{"key":"3436_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2022.12.001","volume":"33","author":"S Avagyan","year":"2023","unstructured":"Avagyan, S., and Zon, L.I. (2023). Clonal hematopoiesis and inflammation\u2014the perpetual cycle. Trends Cell Biol 33, 695\u2013707.","journal-title":"Trends Cell Biol"},{"key":"3436_CR19","doi-asserted-by":"publisher","first-page":"791272","DOI":"10.3389\/fphar.2022.791272","volume":"13","author":"AB Baba","year":"2022","unstructured":"Baba, A.B., Rah, B., Bhat, G.R., Mushtaq, I., Parveen, S., Hassan, R., Hameed Zargar, M., and Afroze, D. (2022). Transforming growth factor-beta (TGF-\u03b2) signaling in cancer\u2014a betrayal within. Front Pharmacol 13, 791272.","journal-title":"Front Pharmacol"},{"key":"3436_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.clml.2015.02.018","volume":"15","author":"T Badar","year":"2015","unstructured":"Badar, T., Cortes, J.E., Ravandi, F., O\u2019Brien, S., Verstovsek, S., Garcia-Manero, G., Kantarjian, H., and Borthakur, G. (2015). Phase I study of S-trans, trans-farnesylthiosalicylic acid (Salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies. Clin Lymphoma Myeloma Leuk 15, 433\u2013438.e2.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3436_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12935-025-03793-z","volume":"25","author":"F Bahmani","year":"2025","unstructured":"Bahmani, F., Shayanmanesh, M., Safari, M., Alaei, A., Yasaman Pouriafar, A., Rasti, Z., Zaker, F., Rostami, S., Damerchiloo, F., and Safa, M. (2025). Bone marrow microenvironment in myelodysplastic neoplasms: insights into pathogenesis, biomarkers, and therapeutic targets. Cancer Cell Int 25, 175.","journal-title":"Cancer Cell Int"},{"key":"3436_CR22","doi-asserted-by":"publisher","first-page":"e13158","DOI":"10.1111\/sji.13158","volume":"95","author":"H Bai","year":"2022","unstructured":"Bai, H., Peng, Y., Li, Y., Duan, J., Fu, W., Liang, X., Yu, W., and Zhang, Q. (2022). Cytarabine-induced TNF\u03b1 promotes the expansion and suppressive functions of myeloid-derived suppressor cells in acute myeloid leukaemia. Scand J Immunol 95, e13158.","journal-title":"Scand J Immunol"},{"key":"3436_CR23","doi-asserted-by":"publisher","first-page":"961473","DOI":"10.3389\/fonc.2022.961473","volume":"12","author":"AK Bains","year":"2022","unstructured":"Bains, A.K., Behrens Wu, L., Rivi\u00e8re, J., Rother, S., Magno, V., Friedrichs, J., Werner, C., Bornh\u00e4user, M., G\u00f6tze, K.S., Cross, M., et al. (2022). Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in myelodysplastic syndromes. Front Oncol 12, 961473.","journal-title":"Front Oncol"},{"key":"3436_CR24","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1038\/s41467-020-15817-5","volume":"11","author":"V Barbier","year":"2020","unstructured":"Barbier, V., Erbani, J., Fiveash, C., Davies, J.M., Tay, J., Tallack, M.R., Lowe, J., Magnani, J.L., Pattabiraman, D.R., Perkins, A.C., et al. (2020). Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance. Nat Commun 11, 2042.","journal-title":"Nat Commun"},{"key":"3436_CR25","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1182\/blood-2019-127307","volume":"134","author":"L Barreyro","year":"2019","unstructured":"Barreyro, L., Sampson, A., Hueneman, K., Choi, K., Christie, S., Wang, D., Huang, G., and Starczynowski, D.T. (2019). Cell-intrinsic inflammation drives progression from myelodysplastic syndromes to leukemia. Blood 134, 2983.","journal-title":"Blood"},{"key":"3436_CR26","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1182\/blood-2012-01-404699","volume":"120","author":"L Barreyro","year":"2012","unstructured":"Barreyro, L., Will, B., Bartholdy, B., Zhou, L., Todorova, T.I., Stanley, R.F., Ben-Neriah, S., Montagna, C., Parekh, S., Pellagatti, A., et al. (2012). Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood 120, 1290\u20131298.","journal-title":"Blood"},{"key":"3436_CR27","doi-asserted-by":"publisher","first-page":"113794","DOI":"10.1016\/j.celrep.2024.113794","volume":"43","author":"B Bassani","year":"2024","unstructured":"Bassani, B., Simonetti, G., Cancila, V., Fiorino, A., Ciciarello, M., Piva, A., Khorasani, A.M., Chiodoni, C., Lecis, D., Gulino, A., et al. (2024). ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion. Cell Rep 43, 113794.","journal-title":"Cell Rep"},{"key":"3436_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12015-024-10761-z","volume":"21","author":"NM Beeraka","year":"2025","unstructured":"Beeraka, N.M., Basappa, B., Nikolenko, V.N., and Mahesh, P.A. (2025). Role of neurotransmitters in steady state hematopoiesis, aging, and leukemia. Stem Cell Rev Rep 21, 2\u201327.","journal-title":"Stem Cell Rev Rep"},{"key":"3436_CR29","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41409-025-02594-2","volume":"60","author":"R Benavente","year":"2025","unstructured":"Benavente, R., Montoro, J., Balaguer-Rosell\u00f3, A., Villalba, M., Chor\u00e3o, P., Asensi, P., Granados, P., Lloret, P., G\u00f3mez-Segu\u00ed, I., Solves, P., et al. (2025). Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCy. Bone Marrow Transplant 60, 1020\u20131026.","journal-title":"Bone Marrow Transplant"},{"key":"3436_CR30","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1038\/s41591-024-03271-5","volume":"30","author":"AS Bhagwat","year":"2024","unstructured":"Bhagwat, A.S., Torres, L., Shestova, O., Shestov, M., Mellors, P.W., Fisher, H.R., Farooki, S.N., Frost, B.F., Loken, M.R., Gaymon, A.L., et al. (2024). Cytokine-mediated CAR T therapy resistance in AML. Nat Med 30, 3697\u20133708.","journal-title":"Nat Med"},{"key":"3436_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.stem.2022.06.012","volume":"29","author":"R Bogeska","year":"2022","unstructured":"Bogeska, R., Mikecin, A.M., Kaschutnig, P., Fawaz, M., B\u00fcchler-Sch\u00e4ff, M., Le, D., Ganuza, M., Vollmer, A., Paffenholz, S.V., Asada, N., et al. (2022). Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging. Cell Stem Cell 29, 1273\u20131284.e8.","journal-title":"Cell Stem Cell"},{"key":"3436_CR32","doi-asserted-by":"publisher","first-page":"7186","DOI":"10.1038\/s41467-022-34965-4","volume":"13","author":"H Bolouri","year":"2022","unstructured":"Bolouri, H., Ries, R.E., Wiedeman, A.E., Hylkema, T., Scheiding, S., Gersuk, V.H., O\u2019Brien, K., Nguyen, Q.A., Smith, J.L., Alice Long, S., et al. (2022). Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes. Nat Commun 13, 7186.","journal-title":"Nat Commun"},{"key":"3436_CR33","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton, K.L., Ptashkin, R.N., Gao, T., Braunstein, L., Devlin, S.M., Kelly, D., Patel, M., Berthon, A., Syed, A., Yabe, M., et al. (2020). Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat Genet 52, 1219\u20131226.","journal-title":"Nat Genet"},{"key":"3436_CR34","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1182\/blood.V126.23.2546.2546","volume":"126","author":"G Borthakur","year":"2015","unstructured":"Borthakur, G., Ofran, Y., Nagler, A., Rowe, J.M., Foran, J.M., Uy, G.L., DiPersio, J.F., Altman, J.K., Frankfurt, O., Tallman, M.S., et al. (2015). The peptidic CXCR4 antagonist, BL-8040, significantly reduces bone marrow immature leukemia progenitors by inducing differentiation, apoptosis and mobilization: results of the dose escalation clinical trial in acute myeloid leukemia. Blood 126, 2546.","journal-title":"Blood"},{"key":"3436_CR35","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1182\/blood.2020006374","volume":"136","author":"E Bulaeva","year":"2020","unstructured":"Bulaeva, E., Pellacani, D., Nakamichi, N., Hammond, C.A., Beer, P.A., Lorzadeh, A., Moksa, M., Carles, A., Bilenky, M., Lefort, S., et al. (2020). MYC-induced human acute myeloid leukemia requires a continuing IL-3\/GM-CSF costimulus. Blood 136, 2764\u20132773.","journal-title":"Blood"},{"key":"3436_CR36","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1182\/blood.2022016835","volume":"141","author":"F Caiado","year":"2023","unstructured":"Caiado, F., Kovtonyuk, L.V., Gonullu, N.G., Fullin, J., Boettcher, S., and Manz, M.G. (2023). Aging drives Tet2+\/\u2212 clonal hematopoiesis via IL-1 signaling. Blood 141, 886\u2013903.","journal-title":"Blood"},{"key":"3436_CR37","doi-asserted-by":"publisher","first-page":"e20201541","DOI":"10.1084\/jem.20201541","volume":"218","author":"F Caiado","year":"2021","unstructured":"Caiado, F., Pietras, E.M., and Manz, M.G. (2021). Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J Exp Med 218, e20201541.","journal-title":"J Exp Med"},{"key":"3436_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-020-00899-x","volume":"13","author":"H Cao","year":"2020","unstructured":"Cao, H., Xiao, J., Reeves, M.E., Payne, K., Chen, C.S., Baylink, D.J., Marcucci, G., and Xu, Y. (2020). Discovery of proangiogenic CD44+mesenchymal cancer stem cells in an acute myeloid leukemia patient\u2019s bone marrow. J Hematol Oncol 13, 63.","journal-title":"J Hematol Oncol"},{"key":"3436_CR39","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1016\/j.celrep.2017.03.018","volume":"18","author":"A Carey","year":"2017","unstructured":"Carey, A., Edwards V, D.K., Eide, C.A., Newell, L., Traer, E., Medeiros, B.C., Pollyea, D. A., Deininger, M.W., Collins, R.H., Tyner, J.W., et al. (2017). Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia. Cell Rep 18, 3204\u20133218.","journal-title":"Cell Rep"},{"key":"3436_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1365-2141.1989.tb00248.x","volume":"73","author":"JA Carron","year":"1989","unstructured":"Carron, J.A., and Cawley, J.C. (1989). IL-2 and myelopoiesis: IL-2 induces blast cell proliferation in some cases of acute myeloid leukaemia. Br J Haematol 73, 168\u2013172.","journal-title":"Br J Haematol"},{"key":"3436_CR41","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1158\/0008-5472.CAN-18-0921","volume":"79","author":"BZ Carter","year":"2019","unstructured":"Carter, B.Z., Mak, P.Y., Wang, X., Tao, W., Ruvolo, V., Mak, D., Mu, H., Burks, J.K., and Andreeff, M. (2019). An ARC-regulated IL1\u03b2\/Cox-2\/PGE2\/\u03b2-catenin\/ARC circuit controls leukemia-microenvironment interactions and confers drug resistance in AML. Cancer Res 79, 1165\u20131177.","journal-title":"Cancer Res"},{"key":"3436_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/imr.12605","volume":"281","author":"G Cavalli","year":"2018","unstructured":"Cavalli, G., and Dinarello, C.A. (2018). Suppression of inflammation and acquired immunity by IL-37. Immunol Rev 281, 179\u2013190.","journal-title":"Immunol Rev"},{"key":"3436_CR43","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol, C., and Girard, J. (2018). Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev 281, 154\u2013168.","journal-title":"Immunol Rev"},{"key":"3436_CR44","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3389\/fonc.2019.01380","volume":"9","author":"MP Chao","year":"2020","unstructured":"Chao, M.P., Takimoto, C.H., Feng, D.D., McKenna, K., Gip, P., Liu, J., Volkmer, J.P., Weissman, I.L., and Majeti, R. (2020). Therapeutic targeting of the macrophage immune checkpoint CD47 in myeloid malignancies. Front Oncol 9, 1380.","journal-title":"Front Oncol"},{"key":"3436_CR45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41375-021-01462-4","volume":"36","author":"A Charlet","year":"2022","unstructured":"Charlet, A., Kappenstein, M., Keye, P., Kl\u00e4sener, K., Endres, C., Poggio, T., Gorantla, S. P., Kreutmair, S., S\u00e4nger, J., Illert, A.L., et al. (2022). The IL-3, IL-5, and GM-CSF common receptor beta chain mediates oncogenic activity of FLT3-ITD-positive AML. Leukemia 36, 701\u2013711.","journal-title":"Leukemia"},{"key":"3436_CR46","doi-asserted-by":"publisher","first-page":"32428","DOI":"10.1038\/srep32428","volume":"6","author":"JY Chen","year":"2016","unstructured":"Chen, J.Y., Lai, Y.S., Tsai, H.J., Kuo, C.C., Yen, B.L., Yeh, S.P., Sun, H.S., and Hung, W. C. (2016). The oncometabolite R-2-hydroxyglutarate activates NF-\u03baB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells. Sci Rep 6, 32428.","journal-title":"Sci Rep"},{"key":"3436_CR47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41408-021-00536-x","volume":"11","author":"N Chen","year":"2021","unstructured":"Chen, N., Xu, Y., Mou, J., Rao, Q., Xing, H., Tian, Z., Tang, K., Wang, M., and Wang, J. (2021). Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells. Blood Cancer J 11, 144.","journal-title":"Blood Cancer J"},{"key":"3436_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.lfs.2019.02.003","volume":"221","author":"T Chen","year":"2019","unstructured":"Chen, T., Zhang, G., Kong, L., Xu, S., Wang, Y., and Dong, M. (2019). Leukemia-derived exosomes induced IL-8 production in bone marrow stromal cells to protect the leukemia cells against chemotherapy. Life Sci 221, 187\u2013195.","journal-title":"Life Sci"},{"key":"3436_CR49","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1182\/bloodadvances.2020001808","volume":"4","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Hoffmeister, L.M., Zaun, Y., Arnold, L., Schmid, K.W., Giebel, B., Klein-Hitpass, L., Hanenberg, H., Squire, A., Reinhardt, H.C., et al. (2020). Acute myeloid leukemia-induced remodeling of the human bone marrow niche predicts clinical outcome. Blood Adv 4, 5257\u20135268.","journal-title":"Blood Adv"},{"key":"3436_CR50","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/leu.2016.347","volume":"31","author":"G Cheng","year":"2017","unstructured":"Cheng, G., Liu, F., Asai, T., Lai, F., Man, N., Xu, H., Chen, S., Greenblatt, S., Hamard, P.J., Ando, K., et al. (2017). Loss of p300 accelerates MDS-associated leukemogenesis. Leukemia 31, 1382\u20131390.","journal-title":"Leukemia"},{"key":"3436_CR51","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1096\/fj.201801931R","volume":"33","author":"J Cheng","year":"2019","unstructured":"Cheng, J., Li, Y., Liu, S., Jiang, Y., Ma, J., Wan, L., Li, Q., and Pang, T. (2019). CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K\/AKT pathway. FASEB J 33, 4755\u20134764.","journal-title":"FASEB J"},{"key":"3436_CR52","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-21-3594","volume":"28","author":"G Corradi","year":"2022","unstructured":"Corradi, G., Bassani, B., Simonetti, G., Sangaletti, S., Vadakekolathu, J., Fontana, M.C., Pazzaglia, M., Gulino, A., Tripodo, C., Cristiano, G., et al. (2022). Release of IFN\u03b3 by acute myeloid leukemia cells remodels bone marrow immune microenvironment by inducing regulatory T cells. Clin Cancer Res 28, 3141\u20133155.","journal-title":"Clin Cancer Res"},{"key":"3436_CR53","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.1038\/s41467-024-53629-z","volume":"15","author":"AE Culver-Cochran","year":"2024","unstructured":"Culver-Cochran, A.E., Hassan, A., Hueneman, K., Choi, K., Ma, A., VanCauwenbergh, B., O\u2019Brien, E., Wunderlich, M., Perentesis, J.P., and Starczynowski, D.T. (2024). Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis. Nat Commun 15, 9189.","journal-title":"Nat Commun"},{"key":"3436_CR54","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/sj.leu.2404485","volume":"21","author":"A Curti","year":"2007","unstructured":"Curti, A., Aluigi, M., Pandolfi, S., Ferri, E., Isidori, A., Salvestrini, V., Durelli, I., Horenstein, A.L., Fiore, F., Massaia, M., et al. (2007). Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. Leukemia 21, 353\u2013355.","journal-title":"Leukemia"},{"key":"3436_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","volume":"33","author":"N Daver","year":"2019","unstructured":"Daver, N., Schlenk, R.F., Russell, N.H., and Levis, M.J. (2019). Targeting FLT3 mutations in AML: review of current knowledge and evidence. Leukemia 33, 299\u2013312.","journal-title":"Leukemia"},{"key":"3436_CR56","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.3324\/haematol.2020.254987","volume":"106","author":"B De Boer","year":"2021","unstructured":"De Boer, B., Sheveleva, S., Apelt, K., Vellenga, E., Mulder, A.B., Huls, G., and Jacob Schuringa, J. (2021). The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis. Haematologica 106, 3067\u20133078.","journal-title":"Haematologica"},{"key":"3436_CR57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41577-024-01003-x","volume":"24","author":"MME de Jong","year":"2024","unstructured":"de Jong, M.M.E., Chen, L., Raaijmakers, M.H.G.P., and Cupedo, T. (2024). Bone marrow inflammation in haematological malignancies. Nat Rev Immunol 24, 543\u2013558.","journal-title":"Nat Rev Immunol"},{"key":"3436_CR58","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","volume":"24","author":"P Desai","year":"2018","unstructured":"Desai, P., Mencia-Trinchant, N., Savenkov, O., Simon, M.S., Cheang, G., Lee, S., Samuel, M., Ritchie, E.K., Guzman, M.L., Ballman, K.V., et al. (2018). Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat Med 24, 1015\u20131023.","journal-title":"Nat Med"},{"key":"3436_CR59","doi-asserted-by":"publisher","first-page":"8602","DOI":"10.1182\/blood-2022-166825","volume":"140","author":"P Desai","year":"2022","unstructured":"Desai, P., Sugita, M., Heise, R., Thies, M., Mencia Trinchant, N., Crispino, C., Griffith-Baker, S., Prifti, R., Kumar, A., Samuel, M., et al. (2022). Association of inflammatory cytokines with clonal hematopoiesis and progression to acute myeloid leukemia. Blood 140, 8602\u20138604.","journal-title":"Blood"},{"key":"3436_CR60","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1182\/blood-2025-3481","volume":"146","author":"Y Ding","year":"2025","unstructured":"Ding, Y., Deng, L., Cao, X., Fan, Z., Xie, J., Shang, Q., Li, Y., Dong, X., Zhao, M., Deng, M., et al. (2025). CD132 expression promotes AML aggressiveness via the JAK-STAT signaling pathway. Blood 146, 3481.","journal-title":"Blood"},{"key":"3436_CR61","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1182\/blood-2005-10-4169","volume":"107","author":"M Dong","year":"2006","unstructured":"Dong, M., and Blobe, G.C. (2006). Role of transforming growth factor-\u03b2 in hematologic malignancies. Blood 107, 4589\u20134596.","journal-title":"Blood"},{"key":"3436_CR62","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.3892\/ol.2015.3720","volume":"10","author":"QM Dong","year":"2015","unstructured":"Dong, Q.M., Ling, C., Zhu, J.F., Chen, X., Tang, Y., and Zhao, L.I. (2015). Correlation between p65 and TNF-\u03b1 in patients with acute myelocytic leukemia. Oncol Lett 10, 3305\u20133309.","journal-title":"Oncol Lett"},{"key":"3436_CR63","doi-asserted-by":"publisher","first-page":"1112059","DOI":"10.3389\/fimmu.2023.1112059","volume":"14","author":"SZ D\u2019Silva","year":"2023","unstructured":"D\u2019Silva, S.Z., Singh, M., and Pinto, A.S. (2023). NK cell defects: implication in acute myeloid leukemia. Front Immunol 14, 1112059.","journal-title":"Front Immunol"},{"key":"3436_CR64","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1182\/blood-2011-12-400051","volume":"119","author":"A Eghtedar","year":"2012","unstructured":"Eghtedar, A., Verstovsek, S., Estrov, Z., Burger, J., Cortes, J., Bivins, C., Faderl, S., Ferrajoli, A., Borthakur, G., George, S., et al. (2012). Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia. Blood 119, 4614\u20134618.","journal-title":"Blood"},{"key":"3436_CR65","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.cyto.2018.05.025","volume":"111","author":"N El Kramani","year":"2018","unstructured":"El Kramani, N., Elsherbiny, N.M., El-Gayar, A.M., Ebrahim, M.A., and Al-Gayyar, M. M.H. (2018). Clinical significance of the TNF-\u03b1 receptors, TNFRSF2 and TNFRSF9, on cell migration molecules Fascin-1 and Versican in acute leukemia. Cytokine 111, 523\u2013529.","journal-title":"Cytokine"},{"key":"3436_CR66","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1182\/blood.V77.5.989.989","volume":"77","author":"O Elbaz","year":"1991","unstructured":"Elbaz, O., Budel, L.M., Hoogerbrugge, H., Touw, I.P., Delwel, R., Mahmoud, L.A., and Lowenberg, B. (1991). Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells. Blood 77, 989\u2013995.","journal-title":"Blood"},{"key":"3436_CR67","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3389\/fcell.2020.00668","volume":"8","author":"J Erbani","year":"2020","unstructured":"Erbani, J., Tay, J., Barbier, V., Levesque, J.P., and Winkler, I.G. (2020). Acute myeloid leukemia chemo-resistance is mediated by E-selectin receptor CD162 in bone marrow niches. Front Cell Dev Biol 8, 668.","journal-title":"Front Cell Dev Biol"},{"key":"3436_CR68","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1182\/blood.V99.12.4343","volume":"99","author":"EH Estey","year":"2002","unstructured":"Estey, E.H., Thall, P.F., Giles, F.J., Wang, X.M., Cortes, J.E., Beran, M., Pierce, S.A., Thomas, D.A., and Kantarjian, H.M. (2002). Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinoside. Blood 99, 4343\u20134349.","journal-title":"Blood"},{"key":"3436_CR69","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41408-023-00962-z","volume":"13","author":"R Fan","year":"2023","unstructured":"Fan, R., Satilmis, H., Vandewalle, N., Verheye, E., De Bruyne, E., Menu, E., De Beule, N., De Becker, A., Ates, G., Massie, A., et al. (2023). Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in acute myeloid leukemia. Blood Cancer J 13, 188.","journal-title":"Blood Cancer J"},{"key":"3436_CR70","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3324\/haematol.2024.286836","volume":"110","author":"J Feng","year":"2025","unstructured":"Feng, J., Gou, J., Wang, Y., Wei, W., Ma, Y., Ren, X., Zhao, C., Cheng, X., Lei, L., Tan, Z., et al. (2025). Bisecting GlcNAc expression by bone marrow stromal cells modulates TGF-\u03b21-driven macrophage polarization in myeloid leukemias. Haematologica 110, 3009\u20133021.","journal-title":"Haematologica"},{"key":"3436_CR71","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41375-024-02246-2","volume":"38","author":"H Fruchtman","year":"2024","unstructured":"Fruchtman, H., Avigan, Z.M., Waksal, J.A., Brennan, N., and Mascarenhas, J.O. (2024). Management of isocitrate dehydrogenase 1\/2 mutated acute myeloid leukemia. Leukemia 38, 927\u2013935.","journal-title":"Leukemia"},{"key":"3436_CR72","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster, J.J., MacLauchlan, S., Zuriaga, M.A., Polackal, M.N., Ostriker, A.C., Chakraborty, R., Wu, C.L., Sano, S., Muralidharan, S., Rius, C., et al. (2017). Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355, 842\u2013847.","journal-title":"Science"},{"key":"3436_CR73","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3324\/haematol.2018.214593","volume":"104","author":"A Gao","year":"2019","unstructured":"Gao, A., Gong, Y., Zhu, C., Yang, W., Li, Q., Zhao, M., Ma, S., Li, J., Hao, S., Cheng, H., et al. (2019). Bone marrow endothelial cell-derived interleukin-4 contributes to thrombocytopenia in acute myeloid leukemia. Haematologica 104, 1950\u20131961.","journal-title":"Haematologica"},{"key":"3436_CR74","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1158\/1535-7163.MCT-17-0456","volume":"16","author":"UA Germann","year":"2017","unstructured":"Germann, U.A., Furey, B.F., Markland, W., Hoover, R.R., Aronov, A.M., Roix, J.J., Hale, M., Boucher, D.M., Sorrell, D.A., Martinez-Botella, G., et al. (2017). Targeting the MAPK signaling pathway in cancer: promising preclinical activity with the novel selective ERK1\/2 inhibitor BVD-523 (Ulixertinib). Mol Cancer Ther 16, 2351\u20132363.","journal-title":"Mol Cancer Ther"},{"key":"3436_CR75","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3324\/haematol.2017.186734","volume":"103","author":"S Geyh","year":"2018","unstructured":"Geyh, S., Rodr\u00edguez-Paredes, M., J\u00e4ger, P., Koch, A., Bormann, F., Gutekunst, J., Zilkens, C., Germing, U., Kobbe, G., Lyko, F., et al. (2018). Transforming growth factor \u03b21-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia. Haematologica 103, 1462\u20131471.","journal-title":"Haematologica"},{"key":"3436_CR76","doi-asserted-by":"publisher","first-page":"17179","DOI":"10.1038\/s41598-025-01711-x","volume":"15","author":"Y Gu","year":"2025","unstructured":"Gu, Y., Xia, J., Guo, Y., Tao, L., Zhang, G., and Xu, J. (2025). Leukemia cells remodel bone marrow stromal cells to generate a protumoral microenvironment via the S100A8-NOX2-ROS signaling pathway. Sci Rep 15, 17179.","journal-title":"Sci Rep"},{"key":"3436_CR77","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11899-018-0472-8","volume":"13","author":"DG Guy","year":"2018","unstructured":"Guy, D.G., and Uy, G.L. (2018). Bispecific antibodies for the treatment of acute myeloid leukemia. Curr Hematol Malig Rep 13, 417\u2013425.","journal-title":"Curr Hematol Malig Rep"},{"key":"3436_CR78","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1182\/bloodadvances.2019001292","volume":"4","author":"J Habbel","year":"2020","unstructured":"Habbel, J., Arnold, L., Chen, Y., M\u00f6llmann, M., Bruderek, K., Brandau, S., D\u00fchrsen, U., and Hanoun, M. (2020). Inflammation-driven activation of JAK\/STAT signaling reversibly accelerates acute myeloid leukemia in vitro. Blood Adv 4, 3000\u20133010.","journal-title":"Blood Adv"},{"key":"3436_CR79","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/cas.12459","volume":"105","author":"Y Han","year":"2014","unstructured":"Han, Y., Ye, A., Bi, L., Wu, J., Yu, K., and Zhang, S. (2014). Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia. Cancer Sci 105, 933\u2013942.","journal-title":"Cancer Sci"},{"key":"3436_CR80","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.stem.2014.06.020","volume":"15","author":"M Hanoun","year":"2014","unstructured":"Hanoun, M., Zhang, D., Mizoguchi, T., Pinho, S., Pierce, H., Kunisaki, Y., Lacombe, J., Armstrong, S.A., D\u00fchrsen, U., and Frenette, P.S. (2014). Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell 15, 365\u2013375.","journal-title":"Cell Stem Cell"},{"key":"3436_CR81","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood.2023020078","volume":"142","author":"RP Hasserjian","year":"2023","unstructured":"Hasserjian, R.P., Germing, U., and Malcovati, L. (2023). Diagnosis and classification of myelodysplastic syndromes. Blood 142, 2247\u20132257.","journal-title":"Blood"},{"key":"3436_CR82","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2141.2008.07411.x","volume":"144","author":"K Hatfield","year":"2009","unstructured":"Hatfield, K., \u00d8yan, A.M., Ersvaer, E., Kalland, K., Lassalle, P., Gjertsen, B.T., and Bruserud, \u00d8. (2009). Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators. Br J Haematol 144, 53\u201368.","journal-title":"Br J Haematol"},{"key":"3436_CR83","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/ijc.22180","volume":"119","author":"K Hatfield","year":"2006","unstructured":"Hatfield, K., Ryningen, A., Corbascio, M., and Bruserud, \u00d8. (2006). Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts. Intl J Cancer 119, 2313\u20132321.","journal-title":"Intl J Cancer"},{"key":"3436_CR84","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1182\/bloodadvances.2023011445","volume":"8","author":"JB Heimlich","year":"2024","unstructured":"Heimlich, J.B., Bhat, P., Parker, A.C., Jenkins, M.T., Vlasschaert, C., Ulloa, J., Van Amburg, J.C., Potts, C.R., Olson, S., Silver, A.J., et al. (2024). Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activation. Blood Adv 8, 3665\u20133678.","journal-title":"Blood Adv"},{"key":"3436_CR85","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1182\/blood.V72.2.823.823","volume":"72","author":"T Hoang","year":"1988","unstructured":"Hoang, T., Haman, A., Goncalves, O., Wong, G.G., and Clark, S.C. (1988). Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia. Blood 72, 823\u2013826.","journal-title":"Blood"},{"key":"3436_CR86","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41419-023-05728-w","volume":"14","author":"P Holicek","year":"2023","unstructured":"Holicek, P., Truxova, I., Rakova, J., Salek, C., Hensler, M., Kovar, M., Reinis, M., Mikyskova, R., Pasulka, J., Vosahlikova, S., et al. (2023). Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients. Cell Death Dis 14, 209.","journal-title":"Cell Death Dis"},{"key":"3436_CR87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40364-021-00304-w","volume":"9","author":"M Hong","year":"2021","unstructured":"Hong, M., Wu, J., Ma, L., Han, X., Lu, T., Wang, Z., Zhao, J., Liu, L., Fu, H., Huang, W., et al. (2021). Inflammation-related genes S100s, RNASE3, and CYBB and risk of leukemic transformation in patients with myelodysplastic syndrome with myelofibrosis. Biomark Res 9, 53.","journal-title":"Biomark Res"},{"key":"3436_CR88","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1038\/s41375-018-0112-2","volume":"32","author":"MM Hosseini","year":"2018","unstructured":"Hosseini, M.M., Kurtz, S.E., Abdelhamed, S., Mahmood, S., Davare, M.A., Kaempf, A., Elferich, J., McDermott, J.E., Liu, T., Payne, S.H., et al. (2018). Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes. Leukemia 32, 2374\u20132387.","journal-title":"Leukemia"},{"key":"3436_CR89","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1182\/bloodadvances.2024015496","volume":"9","author":"D Hou","year":"2025","unstructured":"Hou, D., Cai, D., Dai, W., Liao, X., Tan, M., Zheng, X., Wang, L., Liu, J., Wang, J., Wang, X., et al. (2025). Targeting bone marrow mesenchymal stromal cell-derived IL-6 to overcome acute myeloid leukemia chemoresistance. Blood Adv 9, 4810\u20134824.","journal-title":"Blood Adv"},{"key":"3436_CR90","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1182\/blood.V81.6.1586.1586","volume":"81","author":"JP Hu","year":"1993","unstructured":"Hu, J.P., Cesano, A., Santoli, D., Clark, S.C., and Hoang, T. (1993). Effects of interleukin-11 on the proliferation and cell cycle status of myeloid leukemic cells. Blood 81, 1586\u20131592.","journal-title":"Blood"},{"key":"3436_CR91","doi-asserted-by":"publisher","first-page":"2278229","DOI":"10.1080\/15384047.2023.2278229","volume":"24","author":"S Huang","year":"2023","unstructured":"Huang, S., Zhao, Y., Lai, W., Tan, J., Zheng, X., Zha, X., Li, Y., and Chen, S. (2023). Higher PD-1\/Tim-3 expression on IFN-\u03b3+ T cells is associated with poor prognosis in patients with acute myeloid leukemia. Cancer Biol Ther 24, 2278229.","journal-title":"Cancer Biol Ther"},{"key":"3436_CR92","doi-asserted-by":"publisher","first-page":"e190655","DOI":"10.1172\/jci.insight.190655","volume":"10","author":"S Ito","year":"2025","unstructured":"Ito, S., Geramita, E., Ventura, K., Neupane, B., Bhise, S., Moore, E.M., Furlan, S., and Shlomchik, W.D. (2025). IFN-\u03b3 and donor leukocyte infusions for relapsed myeloblastic malignancies after allogeneic hematopoietic stem cell transplantation. JCI Insight 10, e190655.","journal-title":"JCI Insight"},{"key":"3436_CR93","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1182\/blood-2013-06-511527","volume":"123","author":"R Jacamo","year":"2014","unstructured":"Jacamo, R., Chen, Y., Wang, Z., Ma, W., Zhang, M., Spaeth, E.L., Wang, Y., Battula, V. L., Mak, P.Y., Schallmoser, K., et al. (2014). Reciprocal leukemia-stroma VCAM-1\/VLA-4-dependent activation of NF-\u03baB mediates chemoresistance. Blood 123, 2691\u20132702.","journal-title":"Blood"},{"key":"3436_CR94","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P.V., Mar, B.G., Lindsley, R.C., Mermel, C.H., Burtt, N., Chavez, A., et al. (2014). Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 371, 2488\u20132498.","journal-title":"N Engl J Med"},{"key":"3436_CR95","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","volume":"18","author":"SA Jones","year":"2018","unstructured":"Jones, S.A., and Jenkins, B.J. (2018). Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol 18, 773\u2013789.","journal-title":"Nat Rev Immunol"},{"key":"3436_CR96","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1172\/JCI68101","volume":"124","author":"Y Kagoya","year":"2014","unstructured":"Kagoya, Y., Yoshimi, A., Kataoka, K., Nakagawa, M., Kumano, K., Arai, S., Kobayashi, H., Saito, T., Iwakura, Y., and Kurokawa, M. (2014). Positive feedback between NF-\u03baB and TNF-\u03b1 promotes leukemia-initiating cell capacity. J Clin Invest 124, 528\u2013542.","journal-title":"J Clin Invest"},{"key":"3436_CR97","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-pathmechdis-051222-122724","volume":"19","author":"R Kanagal-Shamanna","year":"2024","unstructured":"Kanagal-Shamanna, R., Beck, D.B., and Calvo, K.R. (2024). Clonal hematopoiesis, inflammation, and hematologic malignancy. Annu Rev Pathol Mech Dis 19, 479\u2013506.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"3436_CR98","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.3390\/jcm10132788","volume":"10","author":"S Kapor","year":"2021","unstructured":"Kapor, S., and Santibanez, J.F. (2021). Myeloid-derived suppressor cells and mesenchymal stem\/stromal cells in myeloid malignancies. J Clin Med 10, 2788.","journal-title":"J Clin Med"},{"key":"3436_CR99","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1182\/blood-2016-02-699363","volume":"130","author":"R Karjalainen","year":"2017","unstructured":"Karjalainen, R., Pemovska, T., Popa, M., Liu, M., Javarappa, K.K., Majumder, M.M., Yadav, B., Tamborero, D., Tang, J., Bychkov, D., et al. (2017). JAK1\/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML. Blood 130, 789\u2013802.","journal-title":"Blood"},{"key":"3436_CR100","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1038\/nrdp.2016.10","volume":"2","author":"A Khwaja","year":"2016","unstructured":"Khwaja, A., Bjorkholm, M., Gale, R.E., Levine, R.L., Jordan, C.T., Ehninger, G., Bloomfield, C.D., Estey, E., Burnett, A., Cornelissen, J.J., et al. (2016). Acute myeloid leukaemia. Nat Rev Dis Primers 2, 16010.","journal-title":"Nat Rev Dis Primers"},{"key":"3436_CR101","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/sj.leu.2401433","volume":"13","author":"T Kimura","year":"1999","unstructured":"Kimura, T., Sakabe, H., Minamiguchi, H., Fujiki, H., Abe, T., Kaneko, H., Yokota, S., Nakagawa, H., Fujii, H., Tamaki, H., et al. (1999). Interleukin-11 (IL-11) enhances clonal proliferation of acute myelogenous leukemia cells with strong expression of the IL-11 receptor \u03b1 chain and signal transducing gp130. Leukemia 13, 1018\u20131027.","journal-title":"Leukemia"},{"key":"3436_CR102","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/cas.14274","volume":"111","author":"H Kiyoi","year":"2020","unstructured":"Kiyoi, H., Kawashima, N., and Ishikawa, Y. (2020). FLT3 mutations in acute myeloid leukemia: therapeutic paradigm beyond inhibitor development. Cancer Sci 111, 312\u2013322.","journal-title":"Cancer Sci"},{"key":"3436_CR103","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.clml.2024.01.007","volume":"24","author":"MY Konopleva","year":"2024","unstructured":"Konopleva, M.Y., Dail, M., Daver, N.G., Garcia, J.S., Jonas, B.A., Yee, K.W.L., Kelly, K. R., Vey, N., Assouline, S., Roboz, G.J., et al. (2024). Venetoclax and cobimetinib in relapsed\/refractory AML: a phase 1b trial. Clin Lymphoma Myeloma Leuk 24, 364\u2013374.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3436_CR104","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2009.813","volume":"301","author":"J Koreth","year":"2009","unstructured":"Koreth, J., Schlenk, R., Kopecky, K.J., Honda, S., Sierra, J., Djulbegovic, B.J., Wadleigh, M., DeAngelo, D.J., Stone, R.M., Sakamaki, H., et al. (2009). Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 301, 2349.","journal-title":"JAMA"},{"key":"3436_CR105","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.3390\/cancers14225656","volume":"14","author":"O Kouroukli","year":"2022","unstructured":"Kouroukli, O., Symeonidis, A., Foukas, P., Maragkou, M.K., and Kourea, E.P. (2022). Bone marrow immune microenvironment in myelodysplastic syndromes. Cancers 14, 5656.","journal-title":"Cancers"},{"key":"3436_CR106","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41375-023-02104-7","volume":"38","author":"I Kovtun","year":"2024","unstructured":"Kovtun, I., von Bonin, M., Ibneeva, L., Frimmel, J., Middeke, J.M., Kunadt, D., Heberling, L., Wobus, M., Bornh\u00e4user, M., and Grinenko, T. (2024). Profound sympathetic neuropathy in the bone marrow of patients with acute myeloid leukemia. Leukemia 38, 393\u2013397.","journal-title":"Leukemia"},{"key":"3436_CR107","doi-asserted-by":"publisher","first-page":"18411","DOI":"10.1038\/srep18411","volume":"5","author":"A Kuett","year":"2015","unstructured":"Kuett, A., Rieger, C., Perathoner, D., Herold, T., Wagner, M., Sironi, S., Sotlar, K., Horny, H.P., Deniffel, C., Drolle, H., et al. (2015). IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia. Sci Rep 5, 18411.","journal-title":"Sci Rep"},{"key":"3436_CR108","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s43018-022-00480-0","volume":"4","author":"A Lasry","year":"2023","unstructured":"Lasry, A., Nadorp, B., Fornerod, M., Nicolet, D., Wu, H., Walker, C.J., Sun, Z., Witkowski, M.T., Tikhonova, A.N., Guillamot-Ruano, M., et al. (2023). An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat Cancer 4, 27\u201342.","journal-title":"Nat Cancer"},{"key":"3436_CR109","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41375-020-0893-y","volume":"35","author":"Q Le","year":"2021","unstructured":"Le, Q., Hadland, B., Meshinchi, S., and Bernstein, I. (2021). Notch blockade overcomes endothelial cell-mediated resistance of FLT3\/ITD-positive AML progenitors to AC220 treatment. Leukemia 35, 601\u2013605.","journal-title":"Leukemia"},{"key":"3436_CR110","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2141.1995.tb05296.x","volume":"91","author":"RM Lemoli","year":"1995","unstructured":"Lemoli, R.M., Fogli, M., Fortuna, A., Amabile, M., Zucchini, P., Grande, A., Martinelli, G., Visani, G., Ferrari, S., and Tura, S. (1995). Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells. Br J Haematol 91, 319\u2013326.","journal-title":"Br J Haematol"},{"key":"3436_CR111","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1182\/blood.V87.9.3852.bloodjournal8793852","volume":"87","author":"RM Lemoli","year":"1996","unstructured":"Lemoli, R.M., Fortuna, A., Tafuri, A., Fogli, M., Amabile, M., Grande, A., Ricciardi, M. R., Petrucci, M.T., Bonsi, L., Bagnara, G., et al. (1996). Interleukin-9 stimulates the proliferation of human myeloid leukemic cells. Blood 87, 3852\u20133859.","journal-title":"Blood"},{"key":"3436_CR112","first-page":"386","volume":"5","author":"RM Lemoli","year":"1991","unstructured":"Lemoli, R.M., Gulati, S.C., Strife, A., Lambek, C., Perez, A., and Clarkson, B.D. (1991). Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Leukemia 5, 386\u2013391.","journal-title":"Leukemia"},{"key":"3436_CR113","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.stemcr.2023.11.003","volume":"19","author":"Y Li","year":"2024","unstructured":"Li, Y., Seet, C.S., Mack, R., Joshi, K., Runde, A.P., Hagen, P.A., Barton, K., Breslin, P., Kini, A., Ji, H.L., et al. (2024). Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia. Stem Cell Rep 19, 100\u2013111.","journal-title":"Stem Cell Rep"},{"key":"3436_CR114","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41590-022-01198-y","volume":"23","author":"Z Li","year":"2022","unstructured":"Li, Z., Ma, R., Ma, S., Tian, L., Lu, T., Zhang, J., Mundy-Bosse, B.L., Zhang, B., Marcucci, G., Caligiuri, M.A., et al. (2022). ILC1s control leukemia stem cell fate and limit development of AML. Nat Immunol 23, 718\u2013730.","journal-title":"Nat Immunol"},{"key":"3436_CR115","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/jcp.27067","volume":"234","author":"B Lin","year":"2019","unstructured":"Lin, B., Zhao, K., Yang, D., Bai, D., Liao, Y., Zhou, Y., Yu, Z., Yu, X., Guo, Q., and Lu, N. (2019). Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis. J Cell Physiol 234, 1913\u20131924.","journal-title":"J Cell Physiol"},{"key":"3436_CR116","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1182\/blood.2023022079","volume":"143","author":"HY Lin","year":"2024","unstructured":"Lin, H.Y., Mohammadhosseini, M., McClatchy, J., Villamor-Pay\u00e0, M., Jeng, S., Bottomly, D., Tsai, C.F., Posso, C., Jacobson, J., Adey, A., et al. (2024). The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1\u03b2-mediated AML progression. Blood 143, 2749\u20132762.","journal-title":"Blood"},{"key":"3436_CR117","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1182\/blood.V88.10.3987.bloodjournal88103987","volume":"88","author":"M Lisovsky","year":"1996","unstructured":"Lisovsky, M., Estrov, Z., Zhang, X., Consoli, U., Sanchez-Williams, G., Snell, V., Munker, R., Goodacre, A., Savchenko, V., and Andreeff, M. (1996). Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax. Blood 88, 3987\u20133997.","journal-title":"Blood"},{"key":"3436_CR118","doi-asserted-by":"publisher","first-page":"1627161","DOI":"10.3389\/fimmu.2025.1627161","volume":"16","author":"M Liu","year":"2025","unstructured":"Liu, M., Yang, M., Qi, Y., Ma, Y., Guo, Q., Guo, L., Liu, C., Liu, W., Xiao, L., and Yang, Y. (2025). Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target. Front Immunol 16, 1627161.","journal-title":"Front Immunol"},{"key":"3436_CR119","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2021.06.014","volume":"520","author":"Q Liu","year":"2021","unstructured":"Liu, Q., Hua, M., Zhang, C., Wang, R., Liu, J., Yang, X., Han, F., Hou, M., and Ma, D. (2021). NLRP3-activated bone marrow dendritic cells play antileukemic roles via IL-1\u03b2\/Th1\/IFN-\u03b3 in acute myeloid leukemia. Cancer Lett 520, 109\u2013120.","journal-title":"Cancer Lett"},{"key":"3436_CR120","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3389\/fonc.2020.00697","volume":"10","author":"S Mardiana","year":"2020","unstructured":"Mardiana, S., and Gill, S. (2020). CAR T cells for acute myeloid leukemia: state of the art and future directions. Front Oncol 10, 697.","journal-title":"Front Oncol"},{"key":"3436_CR121","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm.4484","volume":"24","author":"NR Mathew","year":"2018","unstructured":"Mathew, N.R., Baumgartner, F., Braun, L., O\u2019Sullivan, D., Thomas, S., Waterhouse, M., M\u00fcller, T.A., Hanke, K., Taromi, S., Apostolova, P., et al. (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med 24, 282\u2013291.","journal-title":"Nat Med"},{"key":"3436_CR122","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1084\/jem.20161418","volume":"214","author":"AJ Mead","year":"2017","unstructured":"Mead, A.J., Neo, W.H., Barkas, N., Matsuoka, S., Giustacchini, A., Facchini, R., Thongjuea, S., Jamieson, L., Booth, C.A.G., Fordham, N., et al. (2017). Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation. J Exp Med 214, 2005\u20132021.","journal-title":"J Exp Med"},{"key":"3436_CR123","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/(SICI)1097-0215(19981005)78:2<189::AID-IJC12>3.0.CO;2-6","volume":"78","author":"R Meazza","year":"1998","unstructured":"Meazza, R., Basso, S., Gaggero, A., Detotero, D., Trentin, L., Pereno, R., Azzarone, B., and Ferrini, S. (1998). Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor \u03b2\/\u03b3. Int J Cancer 78, 189\u2013195.","journal-title":"Int J Cancer"},{"key":"3436_CR124","doi-asserted-by":"publisher","first-page":"e152673","DOI":"10.1172\/JCI152673","volume":"132","author":"Y Mei","year":"2022","unstructured":"Mei, Y., Ren, K., Liu, Y., Ma, A., Xia, Z., Han, X., Li, E., Tariq, H., Bao, H., Xie, X., et al. (2022). Bone marrow-confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia. J Clin Invest 132, e152673.","journal-title":"J Clin Invest"},{"key":"3436_CR125","doi-asserted-by":"publisher","first-page":"eaaw8828","DOI":"10.1126\/scitranslmed.aaw8828","volume":"11","author":"K Melgar","year":"2019","unstructured":"Melgar, K., Walker, M.M., Jones, L.Q.M., Bolanos, L.C., Hueneman, K., Wunderlich, M., Jiang, J.K., Wilson, K.M., Zhang, X., Sutter, P., et al. (2019). Overcoming adaptive therapy resistance in AML by targeting immune response pathways. Sci Transl Med 11, eaaw8828.","journal-title":"Sci Transl Med"},{"key":"3436_CR126","doi-asserted-by":"publisher","first-page":"692800","DOI":"10.3389\/fcell.2021.692800","volume":"9","author":"KE Miari","year":"2021","unstructured":"Miari, K.E., Guzman, M.L., Wheadon, H., and Williams, M.T.S. (2021). Macrophages in acute myeloid leukaemia: significant players in therapy resistance and patient outcomes. Front Cell Dev Biol 9, 692800.","journal-title":"Front Cell Dev Biol"},{"key":"3436_CR127","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/bph.16028","volume":"181","author":"KE Miari","year":"2024","unstructured":"Miari, K.E., and Williams, M.T.S. (2024). Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance. Br J Pharmacol 181, 216\u2013237.","journal-title":"Br J Pharmacol"},{"key":"3436_CR128","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1182\/bloodadvances.2019000197","volume":"3","author":"P Milne","year":"2019","unstructured":"Milne, P., Wilhelm-Benartzi, C., Grunwald, M.R., Bigley, V., Dillon, R., Freeman, S.D., Gallagher, K., Publicover, A., Pagan, S., Marr, H., et al. (2019). Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia. Blood Adv 3, 3052\u20133061.","journal-title":"Blood Adv"},{"key":"3436_CR129","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41556-022-01053-0","volume":"25","author":"CA Mitchell","year":"2023","unstructured":"Mitchell, C.A., Verovskaya, E.V., Calero-Nieto, F.J., Olson, O.C., Swann, J.W., Wang, X., H\u00e9rault, A., Dellorusso, P.V., Zhang, S.Y., Svendsen, A.F., et al. (2023). Stromal niche inflammation mediated by IL-1 signalling is a targetable driver of haematopoietic ageing. Nat Cell Biol 25, 30\u201341.","journal-title":"Nat Cell Biol"},{"key":"3436_CR130","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1084\/jem.20180147","volume":"215","author":"K Mitchell","year":"2018","unstructured":"Mitchell, K., Barreyro, L., Todorova, T.I., Taylor, S.J., Antony-Debr\u00e9, I., Narayanagari, S.R., Carvajal, L.A., Leite, J., Piperdi, Z., Pendurti, G., et al. (2018). IL1RAP potentiates multiple oncogenic signaling pathways in AML. J Exp Med 215, 1709\u20131727.","journal-title":"J Exp Med"},{"key":"3436_CR131","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s11427-024-2666-8","volume":"67","author":"X Mo","year":"2024","unstructured":"Mo, X., Zhang, W., Fu, G., Chang, Y., Zhang, X., Xu, L., Wang, Y., Yan, C., Shen, M., Wei, Q., et al. (2024). Single-cell immune landscape of measurable residual disease in acute myeloid leukemia. Sci China Life Sci 67, 2309\u20132322.","journal-title":"Sci China Life Sci"},{"key":"3436_CR132","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s11684-017-0599-3","volume":"13","author":"X Mo","year":"2019","unstructured":"Mo, X., Zhang, X., Xu, L., Wang, Y., Yan, C., Chen, H., Chen, Y., Han, W., Wang, F., Wang, J., et al. (2019). Interferon-\u03b1 salvage treatment is effective for patients with acute leukemia\/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation. Front Med 13, 238\u2013249.","journal-title":"Front Med"},{"key":"3436_CR133","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1634\/theoncologist.2017-0692","volume":"23","author":"XD Mo","year":"2018","unstructured":"Mo, X.D., Wang, Y., Zhang, X.H., Xu, L.P., Yan, C.H., Chen, H., Chen, Y.H., Qin, Y.Z., Liu, K.Y., and Huang, X.J. (2018). Interferon-\u03b1 is effective for treatment of minimal residual disease in patients with t(8;21) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: results of a prospective registry study. Oncologist 23, 1349\u20131357.","journal-title":"Oncologist"},{"key":"3436_CR134","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","volume":"122","author":"F Mussai","year":"2013","unstructured":"Mussai, F., De Santo, C., Abu-Dayyeh, I., Booth, S., Quek, L., McEwen-Smith, R.M., Qureshi, A., Dazzi, F., Vyas, P., and Cerundolo, V. (2013). Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment. Blood 122, 749\u2013758.","journal-title":"Blood"},{"key":"3436_CR135","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bjh.15818","volume":"185","author":"MR Nahas","year":"2019","unstructured":"Nahas, M.R., Stroopinsky, D., Rosenblatt, J., Cole, L., Pyzer, A.R., Anastasiadou, E., Sergeeva, A., Ephraim, A., Washington, A., Orr, S., et al. (2019). Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell\/AML vaccine. Br J Haematol 185, 679\u2013690.","journal-title":"Br J Haematol"},{"key":"3436_CR136","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.3390\/cancers16233974","volume":"16","author":"NS Naji","year":"2024","unstructured":"Naji, N.S., Sathish, M., and Karantanos, T. (2024). Inflammation and related signaling pathways in acute myeloid leukemia. Cancers 16, 3974.","journal-title":"Cancers"},{"key":"3436_CR137","doi-asserted-by":"publisher","first-page":"e0128998","DOI":"10.1371\/journal.pone.0128998","volume":"10","author":"K Nakase","year":"2015","unstructured":"Nakase, K., Kita, K., Kyo, T., Ueda, T., Tanaka, I., Katayama, N., and Bertolini, F. (2015). Prognostic relevance of cytokine receptor expression in acute myeloid leukemia: interleukin-2 receptor \u03b1-chain (CD25) expression predicts a poor prognosis. PLoS One 10, e0128998.","journal-title":"PLoS One"},{"key":"3436_CR138","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41467-019-08871-1","volume":"10","author":"M Noviello","year":"2019","unstructured":"Noviello, M., Manfredi, F., Ruggiero, E., Perini, T., Oliveira, G., Cortesi, F., De Simone, P., Toffalori, C., Gambacorta, V., Greco, R., et al. (2019). Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT. Nat Commun 10, 1065.","journal-title":"Nat Commun"},{"key":"3436_CR139","doi-asserted-by":"publisher","first-page":"926","DOI":"10.6004\/jnccn.2017.0116","volume":"15","author":"MR O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell, M.R., Tallman, M.S., Abboud, C.N., Altman, J.K., Appelbaum, F.R., Arber, D.A., Bhatt, V., Bixby, D., Blum, W., Coutre, S.E., et al. (2017). Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 15, 926\u2013957.","journal-title":"J Natl Compr Canc Netw"},{"key":"3436_CR140","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/sj.leu.2402534","volume":"16","author":"T Padr\u00f3","year":"2002","unstructured":"Padr\u00f3, T., Bieker, R., Ruiz, S., Steins, M., Retzlaff, S., B\u00fcrger, H., B\u00fcchner, T., Kessler, T., Herrera, F., Kienast, J., et al. (2002). Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia 16, 1302\u20131310.","journal-title":"Leukemia"},{"key":"3436_CR141","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.3324\/haematol.2021.279889","volume":"107","author":"R Paolillo","year":"2022","unstructured":"Paolillo, R., Boulanger, M., G\u00e2tel, P., Gabellier, L., De Toledo, M., Temp\u00e9, D., Hallal, R., Akl, D., Moreaux, J., Baik, H., et al. (2022). The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias. Haematologica 107, 2562\u20132575.","journal-title":"Haematologica"},{"key":"3436_CR142","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2017.08.001","volume":"32","author":"D Passaro","year":"2017","unstructured":"Passaro, D., Di Tullio, A., Abarrategi, A., Rouault-Pierre, K., Foster, K., Ariza-McNaughton, L., Montaner, B., Chakravarty, P., Bhaw, L., Diana, G., et al. (2017). Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell 32, 324\u2013341.e6.","journal-title":"Cancer Cell"},{"key":"3436_CR143","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41375-024-02217-7","volume":"38","author":"A Perzolli","year":"2024","unstructured":"Perzolli, A., Koedijk, J.B., Zwaan, C.M., and Heidenreich, O. (2024). Targeting the innate immune system in pediatric and adult AML. Leukemia 38, 1191\u20131201.","journal-title":"Leukemia"},{"key":"3436_CR144","doi-asserted-by":"publisher","first-page":"102254","DOI":"10.1016\/j.eclinm.2023.102254","volume":"64","author":"P Peterlin","year":"2023","unstructured":"Peterlin, P., Garnier, A., Le Bourgeois, A., Guillaume, T., Le Bris, Y., Theisen, O., B\u00e9n\u00e9, M.C., Eveillard, M., Rimbert, M., Jullien, M., et al. (2023). Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial. eClinicalMedicine 64, 102254.","journal-title":"eClinicalMedicine"},{"key":"3436_CR145","doi-asserted-by":"publisher","first-page":"e60823","DOI":"10.1371\/journal.pone.0060823","volume":"8","author":"B Pezeshkian","year":"2013","unstructured":"Pezeshkian, B., Donnelly, C., Tamburo, K., Geddes, T., Madlambayan, G.J., and St-Pierre, Y. (2013). Leukemia mediated endothelial cell activation modulates leukemia cell susceptibility to chemotherapy through a positive feedback loop mechanism. PLoS One 8, e60823.","journal-title":"PLoS One"},{"key":"3436_CR146","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1182\/blood-2016-07-730614","volume":"129","author":"AR Pyzer","year":"2017","unstructured":"Pyzer, A.R., Stroopinsky, D., Rajabi, H., Washington, A., Tagde, A., Coll, M., Fung, J., Bryant, M.P., Cole, L., Palmer, K., et al. (2017). MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia. Blood 129, 1791\u20131801.","journal-title":"Blood"},{"key":"3436_CR147","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40164-022-00309-7","volume":"11","author":"W Qiao","year":"2022","unstructured":"Qiao, W., Young, E., Feng, C., Liu, S., Jin, J., Noor, L., Rojas Hernandez, C.M., Borthakur, G., Gorlova, O., and Afshar-Kharghan, V. (2022). Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia. Exp Hematol Oncol 11, 58.","journal-title":"Exp Hematol Oncol"},{"key":"3436_CR148","doi-asserted-by":"publisher","first-page":"61069","DOI":"10.18632\/oncotarget.11179","volume":"7","author":"L Qin","year":"2016","unstructured":"Qin, L., Dominguez, D., Chen, S., Fan, J., Long, A., Zhang, M., Fang, D., Zhang, Y., Kuzel, T.M., and Zhang, B. (2016). Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia. Oncotarget 7, 61069\u201361080.","journal-title":"Oncotarget"},{"key":"3436_CR149","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1182\/blood.2024024000","volume":"144","author":"R Radpour","year":"2024","unstructured":"Radpour, R., Simillion, C., Wang, B., Abbas, H.A., Riether, C., and Ochsenbein, A.F. (2024). IL-9 secreted by leukemia stem cells induces Th1-skewed CD4+ T cells, which promote their expansion. Blood 144, 888\u2013903.","journal-title":"Blood"},{"key":"3436_CR150","doi-asserted-by":"publisher","first-page":"623952","DOI":"10.3389\/fonc.2021.623952","volume":"11","author":"C R\u00e9cher","year":"2021","unstructured":"R\u00e9cher, C. (2021). Clinical implications of inflammation in acute myeloid leukemia. Front Oncol 11, 623952.","journal-title":"Front Oncol"},{"key":"3436_CR151","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.3390\/cancers15205086","volume":"15","author":"P Reichelt","year":"2023","unstructured":"Reichelt, P., Bernhart, S., Wilke, F., Schwind, S., Cross, M., Platzbecker, U., and Behre, G. (2023). MicroRNA expression patterns reveal a role of the TGF-\u03b2 family signaling in AML chemo-resistance. Cancers 15, 5086.","journal-title":"Cancers"},{"key":"3436_CR152","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/toxins5020336","volume":"5","author":"H Reikvam","year":"2013","unstructured":"Reikvam, H., Fredly, H., Kittang, A., and Bruserud, \u00d8. (2013). The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine\u2014the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation. Toxins 5, 336\u2013362.","journal-title":"Toxins"},{"key":"3436_CR153","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1517\/13543780903485659","volume":"19","author":"H Reikvam","year":"2010","unstructured":"Reikvam, H., Hatfield, K.J., Lassalle, P., Olsnes Kittang, A., Ersv\u00e6r, E., and Bruserud, \u00d8. (2010). Targeting the angiopoietin (Ang)\/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release. Expert Opin Investal Drugs 19, 169\u2013183.","journal-title":"Expert Opin Investal Drugs"},{"key":"3436_CR154","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bbmt.2011.10.007","volume":"18","author":"H Reikvam","year":"2012","unstructured":"Reikvam, H., Mosevoll, K.A., Melve, G.K., G\u00fcnther, C.C., Sjo, M., Bentsen, P.T., and Bruserud, \u00d8. (2012). The pretransplantation serum cytokine profile in allogeneic stem cell recipients differs from healthy individuals, and various profiles are associated with different risks of posttransplantation complications. Biol Blood Marrow Transplant 18, 190\u2013199.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3436_CR155","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","volume":"157","author":"JA Rickard","year":"2014","unstructured":"Rickard, J.A., O\u2019Donnell, J.A., Evans, J.M., Lalaoui, N., Poh, A.R., Rogers, T.W., Vince, J.E., Lawlor, K.E., Ninnis, R.L., Anderton, H., et al. (2014). RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175\u20131188.","journal-title":"Cell"},{"key":"3436_CR156","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s44222-025-00305-6","volume":"3","author":"T Rogkoti","year":"2025","unstructured":"Rogkoti, T., Donnelly, H., Dalby, M.J., and Salmeron-Sanchez, M. (2025). Mechanical signatures and models of the bone marrow niche. Nat Rev Bioeng 3, 697\u2013713.","journal-title":"Nat Rev Bioeng"},{"key":"3436_CR157","doi-asserted-by":"publisher","first-page":"634044","DOI":"10.3389\/fcell.2021.634044","volume":"9","author":"FM Roversi","year":"2021","unstructured":"Roversi, F.M., Bueno, M.L.P., Pericole, F.V., and Saad, S.T.O. (2021). Hematopoietic cell kinase (HCK) is a player of the crosstalk between hematopoietic cells and bone marrow niche through CXCL12\/CXCR4 axis. Front Cell Dev Biol 9, 634044.","journal-title":"Front Cell Dev Biol"},{"key":"3436_CR158","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3324\/haematol.2021.280161","volume":"107","author":"JM Rowe","year":"2022","unstructured":"Rowe, J.M. (2022). The \u201c7+3\u201d regimen in acute myeloid leukemia. Haematologica 107, 3.","journal-title":"Haematologica"},{"key":"3436_CR159","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1189\/jlb.2AB1013-559R","volume":"96","author":"T Sadras","year":"2014","unstructured":"Sadras, T., Perugini, M., Kok, C.H., Iarossi, D.G., Heatley, S.L., Brumatti, G., Samuel, M.S., To, L.B., Lewis, I.D., Lopez, A.F., et al. (2014). Interleukin-3-mediated regulation of \u03b2-catenin in myeloid transformation and acute myeloid leukemia. J Leukoc Biol 96, 83\u201391.","journal-title":"J Leukoc Biol"},{"key":"3436_CR160","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.cyto.2012.12.023","volume":"61","author":"B Sanchez-Correa","year":"2013","unstructured":"Sanchez-Correa, B., Bergua, J.M., Campos, C., Gayoso, I., Arcos, M.J., Ba\u00f1as, H., Morgado, S., Casado, J.G., Solana, R., and Tarazona, R. (2013). Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels. Cytokine 61, 885\u2013891.","journal-title":"Cytokine"},{"key":"3436_CR161","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/cncr.33458","volume":"127","author":"K Sasaki","year":"2021","unstructured":"Sasaki, K., Ravandi, F., Kadia, T.M., DiNardo, C.D., Short, N.J., Borthakur, G., Jabbour, E., and Kantarjian, H.M. (2021). De novo acute myeloid leukemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Cancer 127, 2049\u20132061.","journal-title":"Cancer"},{"key":"3436_CR162","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1182\/blood-2015-01-621631","volume":"125","author":"C Schinke","year":"2015","unstructured":"Schinke, C., Giricz, O., Li, W., Shastri, A., Gordon, S., Barreyro, L., Bhagat, T., Bhattacharyya, S., Ramachandra, N., Bartenstein, M., et al. (2015). IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood 125, 3144\u20133152.","journal-title":"Blood"},{"key":"3436_CR163","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-015-0189-2","volume":"8","author":"FM Schnorfeil","year":"2015","unstructured":"Schnorfeil, F.M., Lichtenegger, F.S., Emmerig, K., Schlueter, M., Neitz, J.S., Draenert, R., Hiddemann, W., and Subklewe, M. (2015). T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol 8, 93.","journal-title":"J Hematol Oncol"},{"key":"3436_CR164","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/sj.leu.2403824","volume":"19","author":"G Schuch","year":"2005","unstructured":"Schuch, G., Oliveira-Ferrer, L., Loges, S., Laack, E., Bokemeyer, C., Hossfeld, D.K., Fiedler, W., and Ergun, S. (2005). Antiangiogenic treatment with endostatin inhibits progression of AML in vivo. Leukemia 19, 1312\u20131317.","journal-title":"Leukemia"},{"key":"3436_CR165","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00432-021-03695-3","volume":"148","author":"L Schwenk","year":"2022","unstructured":"Schwenk, L., Wittig, S., and Gruhn, B. (2022). Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies. J Cancer Res Clin Oncol 148, 985\u2013991.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3436_CR166","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1182\/bloodadvances.2022009468","volume":"7","author":"S Shahid","year":"2023","unstructured":"Shahid, S., Ceglia, N., Le Luduec, J.B., McPherson, A., Spitzer, B., Kontopoulos, T., Bojilova, V., Panjwani, M.K., Roshal, M., Shah, S.P., et al. (2023). Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia. Blood Adv 7, 5069\u20135081.","journal-title":"Blood Adv"},{"key":"3436_CR167","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis, R.M., Wang, R., Davidoff, A., Ma, X., and Zeidan, A.M. (2019). Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev 36, 70\u201387.","journal-title":"Blood Rev"},{"key":"3436_CR168","doi-asserted-by":"publisher","first-page":"115976","DOI":"10.1016\/j.biopha.2023.115976","volume":"170","author":"Q Shang","year":"2024","unstructured":"Shang, Q., Yu, X., Sun, Q., Li, H., Sun, C., and Liu, L. (2024). Polysaccharides regulate Th1\/Th2 balance: a new strategy for tumor immunotherapy. Biomed Pharmacother 170, 115976.","journal-title":"Biomed Pharmacother"},{"key":"3436_CR169","doi-asserted-by":"publisher","first-page":"757002","DOI":"10.3389\/fimmu.2022.757002","volume":"13","author":"MZ Shen","year":"2022","unstructured":"Shen, M.Z., Zhang, X.H., Xu, L.P., Wang, Y., Yan, C.H., Chen, H., Chen, Y.H., Han, W., Wang, F.R., Wang, J.Z., et al. (2022). Preemptive interferon-\u03b1 therapy could protect against relapse and improve survival of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation: long-term results of two registry studies. Front Immunol 13, 757002.","journal-title":"Front Immunol"},{"key":"3436_CR170","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony, S., Stahl, M., and Stone, R.M. (2025). Acute myeloid leukemia: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol 100, 860\u2013891.","journal-title":"Am J Hematol"},{"key":"3436_CR171","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","volume":"392","author":"NJ Short","year":"2018","unstructured":"Short, N.J., Rytting, M.E., and Cortes, J.E. (2018). Acute myeloid leukaemia. Lancet 392, 593\u2013606.","journal-title":"Lancet"},{"key":"3436_CR172","doi-asserted-by":"publisher","first-page":"1258151","DOI":"10.3389\/fphar.2023.1258151","volume":"14","author":"T Smoljo","year":"2023","unstructured":"Smoljo, T., Tomic, B., Lalic, H., Dembitz, V., Batinic, J., Bedalov, A., and Visnjic, D. (2023). Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia. Front Pharmacol 14, 1258151.","journal-title":"Front Pharmacol"},{"key":"3436_CR173","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma, D.P., Bejar, R., Jaiswal, S., Lindsley, R.C., Sekeres, M.A., Hasserjian, R.P., and Ebert, B.L. (2015). Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 126, 9\u201316.","journal-title":"Blood"},{"key":"3436_CR174","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/10428194.2023.2300710","volume":"65","author":"EM Stein","year":"2024","unstructured":"Stein, E.M., Fathi, A.T., Harb, W.A., Colak, G., Fusco, A., and Mangan, J.K. (2024). Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies. Leuk Lymphoma 65, 503\u2013510.","journal-title":"Leuk Lymphoma"},{"key":"3436_CR175","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/08880018.2022.2089790","volume":"40","author":"AM Stevens","year":"2023","unstructured":"Stevens, A.M., Horton, T.M., Glasser, C.L., Gerbing, R.B., Aplenc, R., Alonzo, T.A., and Redell, M.S. (2023). IL-10 and TNF\u03b1 are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children\u2019s oncology group report. Pediatr Hematol Oncol 40, 147\u2013158.","journal-title":"Pediatr Hematol Oncol"},{"key":"3436_CR176","doi-asserted-by":"publisher","first-page":"e13076","DOI":"10.1111\/cpr.13076","volume":"54","author":"L Su","year":"2021","unstructured":"Su, L., Hu, Z., and Yang, Y. (2021). Role of CXCR4 in the progression and therapy of acute leukaemia. Cell Prolif 54, e13076.","journal-title":"Cell Prolif"},{"key":"3436_CR177","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41375-021-01487-9","volume":"36","author":"KI Sunthankar","year":"2022","unstructured":"Sunthankar, K.I., Jenkins, M.T., Cote, C.H., Patel, S.B., Welner, R.S., and Ferrell, P.B. (2022). Isocitrate dehydrogenase mutations are associated with altered IL-1\u03b2 responses in acute myeloid leukemia. Leukemia 36, 923\u2013934.","journal-title":"Leukemia"},{"key":"3436_CR178","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2147\/ITT.S512700","volume":"14","author":"V \u0160vubov\u00e1","year":"2025","unstructured":"\u0160vubov\u00e1, V., Janstov\u00e1, L., Jedli\u010dka, M., Ma\u0161\u00ednov\u00e1, E., Szabov\u00e1, J., Feglarov\u00e1, T., Kuglerov\u00e1, K., Bos\u00e1kov\u00e1, V., Brodsk\u00e1, B., Bor\u00e1kov\u00e1, K., et al. (2025). TGF-\u03b2 decreases NK cell mobility and cytotoxic efficacy in complex in vitro models of the leukemia microenvironment. Immunotargets Ther Volume 14, 589\u2013604.","journal-title":"Immunotargets Ther Volume"},{"key":"3436_CR179","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1182\/bloodadvances.2021006195","volume":"6","author":"J Swatler","year":"2022","unstructured":"Swatler, J., Turos-Korgul, L., Brewinska-Olchowik, M., De Biasi, S., Dudka, W., Le, B. V., Kominek, A., Cyranowski, S., Pilanc, P., Mohammadi, E., et al. (2022). 4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells. Blood Adv 6, 1879\u20131894.","journal-title":"Blood Adv"},{"key":"3436_CR180","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s11427-024-2974-3","volume":"69","author":"F Tang","year":"2026","unstructured":"Tang, F., Wang, Y., Zhang, Y., Zhang, H., Ren, J., He, P., Xu, Y., Yan, H., Jia, Y., Dou, L., et al. (2026). The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in China. Sci China Life Sci 69, 214\u2013223.","journal-title":"Sci China Life Sci"},{"key":"3436_CR181","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1002\/ijc.29563","volume":"137","author":"Q Tao","year":"2015","unstructured":"Tao, Q., Pan, Y., Wang, Y., Wang, H., Xiong, S., Li, Q., Wang, J., Tao, L., Wang, Z., Wu, F., et al. (2015). Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts. Intl J Cancer 137, 2384\u20132393.","journal-title":"Intl J Cancer"},{"key":"3436_CR182","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/2767-9764.CRC-24-0310","volume":"4","author":"A Tasis","year":"2024","unstructured":"Tasis, A., Papaioannou, N.E., Grigoriou, M., Paschalidis, N., Loukogiannaki, C., Filia, A., Katsiki, K., Lamprianidou, E., Papadopoulos, V., Rimpa, C.M., et al. (2024). Single-cell analysis of bone marrow CD8+ T cells in myeloid neoplasms reveals pathways associated with disease progression and response to treatment with azacitidine. Cancer Res Commun 4, 3067\u20133083.","journal-title":"Cancer Res Commun"},{"key":"3436_CR183","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/cancers17050749","volume":"17","author":"A Tasis","year":"2025","unstructured":"Tasis, A., Spyropoulos, T., and Mitroulis, I. (2025). The emerging role of CD8+ T cells in shaping treatment outcomes of patients with MDS and AML. Cancers 17, 749.","journal-title":"Cancers"},{"key":"3436_CR184","doi-asserted-by":"publisher","first-page":"11673","DOI":"10.1038\/s41598-025-96660-w","volume":"15","author":"S Tausch","year":"2025","unstructured":"Tausch, S., Villinger, C., Alexe, G., Urban, D.J., Shen, M., Jahn, D., Vischedyk, J., Scheich, S., Serve, H., Hall, M.D., et al. (2025). Inflammatory signaling pathways play a role in SYK inhibitor resistant AML. Sci Rep 15, 11673.","journal-title":"Sci Rep"},{"key":"3436_CR185","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1182\/blood-2002-03-0852","volume":"100","author":"U Testa","year":"2002","unstructured":"Testa, U., Riccioni, R., Militi, S., Coccia, E., Stellacci, E., Samoggia, P., Latagliata, R., Mariani, G., Rossini, A., Battistini, A., et al. (2002). Elevated expression of IL-3R\u03b1 in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood 100, 2980\u20132988.","journal-title":"Blood"},{"key":"3436_CR186","doi-asserted-by":"publisher","first-page":"1320497","DOI":"10.3389\/fimmu.2023.1320497","volume":"14","author":"C Tomasoni","year":"2023","unstructured":"Tomasoni, C., Arsuffi, C., Donsante, S., Corsi, A., Riminucci, M., Biondi, A., Pievani, A., and Serafini, M. (2023). AML alters bone marrow stromal cell osteogenic commitment via Notch signaling. Front Immunol 14, 1320497.","journal-title":"Front Immunol"},{"key":"3436_CR187","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00262-023-03594-1","volume":"73","author":"R Towers","year":"2024","unstructured":"Towers, R., Trombello, L., Fusenig, M., Tunger, A., Baumann, A.L., Savoldelli, R., Wehner, R., Fasslrinner, F., Arndt, C., Dazzi, F., et al. (2024). Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype. Cancer Immunol Immunother 73, 8.","journal-title":"Cancer Immunol Immunother"},{"key":"3436_CR188","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.3324\/haematol.2014.119602","volume":"100","author":"S Trabanelli","year":"2015","unstructured":"Trabanelli, S., Curti, A., Lecciso, M., Salome, B., Riether, C., Ochsenbein, A., Romero, P., and Jandus, C. (2015). CD127+ innate lymphoid cells are dysregulated in treatment naive acute myeloid leukemia patients at diagnosis. Haematologica 100, e257\u2013e260.","journal-title":"Haematologica"},{"key":"3436_CR189","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1158\/0008-5472.CAN-17-1098","volume":"77","author":"C Tripodo","year":"2017","unstructured":"Tripodo, C., Burocchi, A., Piccaluga, P.P., Chiodoni, C., Portararo, P., Cappetti, B., Botti, L., Gulino, A., Isidori, A., Liso, A., et al. (2017). Persistent immune stimulation exacerbates genetically driven myeloproliferative disorders via stromal remodeling. Cancer Res 77, 3685\u20133699.","journal-title":"Cancer Res"},{"key":"3436_CR190","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41375-023-02086-6","volume":"38","author":"A Tyagi","year":"2024","unstructured":"Tyagi, A., Jaggupilli, A., Ly, S., Yuan, B., El-Dana, F., Hegde, V.L., Anand, V., Kumar, B., Puppala, M., Yin, Z., et al. (2024). TP-0184 inhibits FLT3\/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax. Leukemia 38, 82\u201395.","journal-title":"Leukemia"},{"key":"3436_CR191","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/cancers10070219","volume":"10","author":"I Uehara","year":"2018","unstructured":"Uehara, I., and Tanaka, N. (2018). Role of p53 in the regulation of the inflammatory tumor microenvironment and tumor suppression. Cancers 10, 219.","journal-title":"Cancers"},{"key":"3436_CR192","doi-asserted-by":"publisher","first-page":"101184","DOI":"10.1016\/j.blre.2024.101184","volume":"65","author":"GL Uy","year":"2024","unstructured":"Uy, G.L., DeAngelo, D.J., Lozier, J.N., Fisher, D.M., Jonas, B.A., Magnani, J.L., Becker, P.S., Lazarus, H.M., and Winkler, I.G. (2024). Targeting hematologic malignancies by inhibiting E-selectin: a sweet spot for AML therapy? Blood Rev 65, 101184.","journal-title":"Blood Rev"},{"key":"3436_CR193","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1182\/bloodadvances.2020002512","volume":"4","author":"J Vadakekolathu","year":"2020","unstructured":"Vadakekolathu, J., Lai, C., Reeder, S., Church, S.E., Hood, T., Lourdusamy, A., Rettig, M.P., Aldoss, I., Advani, A.S., Godwin, J., et al. (2020). TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML. Blood Adv 4, 5011\u20135024.","journal-title":"Blood Adv"},{"key":"3436_CR194","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1182\/blood.2023019961","volume":"143","author":"J Vadakekolathu","year":"2024","unstructured":"Vadakekolathu, J., and Rutella, S. (2024). Escape from T-cell-targeting immunotherapies in acute myeloid leukemia. Blood 143, 2689\u20132700.","journal-title":"Blood"},{"key":"3436_CR195","doi-asserted-by":"publisher","first-page":"2100072","DOI":"10.1002\/prca.202100072","volume":"16","author":"AD van Dijk","year":"2022","unstructured":"van Dijk, A.D., Hoff, F.W., Qiu, Y., Gerbing, R.B., Gamis, A.S., Aplenc, R., Kolb, E.A., Alonzo, T.A., Meshinchi, S., Jenkins, G.N., et al. (2022). Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-\u03baB subunit RelA. Proteomics Clin Apps 16, 2100072.","journal-title":"Proteomics Clin Apps"},{"key":"3436_CR196","doi-asserted-by":"publisher","first-page":"2152998","DOI":"10.1080\/2162402X.2022.2152998","volume":"12","author":"CK Vaxevanis","year":"2023","unstructured":"Vaxevanis, C.K., Bauer, M., Subbarayan, K., Friedrich, M., Massa, C., Biehl, K., Al-Ali, H.K., Wickenhauser, C., and Seliger, B. (2023). Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. OncoImmunology 12, 2152998.","journal-title":"OncoImmunology"},{"key":"3436_CR197","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.arcmed.2020.10.013","volume":"52","author":"J Vela-Ojeda","year":"2021","unstructured":"Vela-Ojeda, J., Cardenas, P.V., Garcia-Ruiz Esparza, M.A., Montiel Cervantes, L.A., Chavez, J.G., Caballero, A.H., Majluf-Cruz, A., Vega-L\u00f3pez, A., and Reyes-Maldonado, E. (2021). FLT3-ITD and CD135 over-expression are frequent findings of poor survival in adult patients with acute leukemias. Arch Med Res 52, 217\u2013223.","journal-title":"Arch Med Res"},{"key":"3436_CR198","first-page":"e24835","volume":"14","author":"S Verma","year":"2022","unstructured":"Verma, S., Singh, A., Yadav, G., Kushwaha, R., Ali, W., Verma, S.P., and Singh, U.S. (2022). Serum tumor necrosis factor-alpha levels in acute leukemia and its prognostic significance. Cureus 14, e24835.","journal-title":"Cureus"},{"key":"3436_CR199","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3324\/haematol.2023.284944","volume":"110","author":"MT Villaume","year":"2025","unstructured":"Villaume, M.T., and Savona, M.R. (2025). Pathogenesis and inflammaging in myelodysplastic syndrome. Haematologica 110, 283\u2013299.","journal-title":"Haematologica"},{"key":"3436_CR200","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/1878-0261.12640","volume":"14","author":"S Waldeck","year":"2020","unstructured":"Waldeck, S., Rassner, M., Keye, P., Follo, M., Herchenbach, D., Endres, C., Charlet, A., Andrieux, G., Salzer, U., Boerries, M., et al. (2020). CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML. Mol Oncol 14, 779\u2013794.","journal-title":"Mol Oncol"},{"key":"3436_CR201","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12964-020-00538-5","volume":"18","author":"J Wan","year":"2020","unstructured":"Wan, J., Wu, Y., Ji, X., Huang, L., Cai, W., Su, Z., Wang, S., and Xu, H. (2020). IL-9 and IL-9-producing cells in tumor immunity. Cell Commun Signal 18, 50.","journal-title":"Cell Commun Signal"},{"key":"3436_CR202","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41467-024-45916-6","volume":"15","author":"B Wang","year":"2024","unstructured":"Wang, B., Reville, P.K., Yassouf, M.Y., Jelloul, F.Z., Ly, C., Desai, P.N., Wang, Z., Borges, P., Veletic, I., Dasdemir, E., et al. (2024a). Comprehensive characterization of IFN\u03b3 signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nat Commun 15, 1821.","journal-title":"Nat Commun"},{"key":"3436_CR203","doi-asserted-by":"publisher","first-page":"10602","DOI":"10.1002\/jcp.27735","volume":"234","author":"B Wang","year":"2019","unstructured":"Wang, B., Wang, X., Hou, D., Huang, Q., Zhan, W., Chen, C., Liu, J., You, R., Xie, J., Chen, P., et al. (2019). Exosomes derived from acute myeloid leukemia cells promote chemoresistance by enhancing glycolysis-mediated vascular remodeling. J Cell Physiol 234, 10602\u201310614.","journal-title":"J Cell Physiol"},{"key":"3436_CR204","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.humimm.2015.09.020","volume":"76","author":"J Wang","year":"2015","unstructured":"Wang, J., Tao, Q., Wang, H., Wang, Z., Wu, F., Pan, Y., Tao, L., Xiong, S., Wang, Y., and Zhai, Z. (2015). Elevated IL-35 in bone marrow of the patients with acute myeloid leukemia. Hum Immunol 76, 681\u2013686.","journal-title":"Hum Immunol"},{"key":"3436_CR205","doi-asserted-by":"publisher","first-page":"595053","DOI":"10.3389\/fimmu.2020.595053","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Su, H., Yan, M., Zhang, L., Tang, J., Li, Q., Gu, X., and Gong, Q. (2020). Interleukin-33 promotes cell survival via p38 MAPK-mediated interleukin-6 gene expression and release in pediatric AML. Front Immunol 11, 595053.","journal-title":"Front Immunol"},{"key":"3436_CR206","doi-asserted-by":"publisher","first-page":"217290","DOI":"10.1016\/j.canlet.2024.217290","volume":"605","author":"ZK Wang","year":"2024","unstructured":"Wang, Z.K., Zhang, Z.W., Lyu, Z.S., Xing, T., Liang, M., Shen, M.Z., Li, C.Y., Zhang, X. Y., Chen, D.D., Wang, Y.Z., et al. (2024b). Inhibition of TGF-\u03b2 signaling in bone marrow endothelial cells promotes hematopoietic recovery in acute myeloid leukemia patients. Cancer Lett 605, 217290.","journal-title":"Cancer Lett"},{"key":"3436_CR207","first-page":"1599","volume":"136","author":"JT Warren","year":"2020","unstructured":"Warren, J.T., and Link, D.C. (2020). Clonal hematopoiesis and risk for hematologic malignancy. Blood 136, 1599\u20131605.","journal-title":"Blood"},{"key":"3436_CR208","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.2147\/CMAR.S303017","volume":"13","author":"X Wei","year":"2021","unstructured":"Wei, X., Li, Y., Zhang, G., Wang, N., Mi, M., Xin, Y., Jiang, H., and Sun, C. (2021). IL-37 was involved in progress of acute myeloid leukemia through regulating IL-6 expression. Cancer Manag Res Volume 13, 3393\u20133402.","journal-title":"Cancer Manag Res Volume"},{"key":"3436_CR209","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1182\/bloodadvances.2018022053","volume":"2","author":"C Wenk","year":"2018","unstructured":"Wenk, C., Garz, A.K., Grath, S., Huberle, C., Witham, D., Weickert, M., Malinverni, R., Niggemeyer, J., Kyncl, M., Hecker, J., et al. (2018). Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis. Blood Adv 2, 3447\u20133461.","journal-title":"Blood Adv"},{"key":"3436_CR210","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/nm.2969","volume":"18","author":"IG Winkler","year":"2012","unstructured":"Winkler, I.G., Barbier, V., Nowlan, B., Jacobsen, R.N., Forristal, C.E., Patton, J.T., Magnani, J.L., and L\u00e9vesque, J.P. (2012). Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nat Med 18, 1651\u20131657.","journal-title":"Nat Med"},{"key":"3436_CR211","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/s41375-024-02226-6","volume":"38","author":"S Winter","year":"2024","unstructured":"Winter, S., G\u00f6tze, K.S., Hecker, J.S., Metzeler, K.H., Guezguez, B., Woods, K., Medyouf, H., Sch\u00e4ffer, A., Schmitz, M., Wehner, R., et al. (2024). Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche. Leukemia 38, 936\u2013946.","journal-title":"Leukemia"},{"key":"3436_CR212","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40164-025-00635-6","volume":"14","author":"J Wu","year":"2025","unstructured":"Wu, J., Li, X., Liu, Y., Chen, G., Li, R., Jiang, H., Yin, W., Tong, X., Cao, R., Wang, X., et al. (2025). MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK\/STAT pathway. Exp Hematol Oncol 14, 43.","journal-title":"Exp Hematol Oncol"},{"key":"3436_CR213","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/bjh.15548","volume":"183","author":"L Wu","year":"2018","unstructured":"Wu, L., Amarachintha, S., Xu, J., Oley Jr, F., and Du, W. (2018). Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity. Br J Haematol 183, 445\u2013456.","journal-title":"Br J Haematol"},{"key":"3436_CR214","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1038\/s41375-020-0843-8","volume":"34","author":"L Wu","year":"2020","unstructured":"Wu, L., Lin, Q., Ma, Z., Chowdhury, F.A., Mazumder, M.H.H., and Du, W. (2020). Mesenchymal PGD2 activates an ILC2-Treg axis to promote proliferation of normal and malignant HSPCs. Leukemia 34, 3028\u20133041.","journal-title":"Leukemia"},{"key":"3436_CR215","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.18632\/oncotarget.14325","volume":"8","author":"Y Wu","year":"2017","unstructured":"Wu, Y., Su, M., Zhang, S.X., Cheng, Y., Liao, X.Y., Lin, B.Y., and Chen, Y.Z. (2017). Abnormal expression of TGF-beta type II receptor isoforms contributes to acute myeloid leukemia. Oncotarget 8, 10037\u201310049.","journal-title":"Oncotarget"},{"key":"3436_CR216","doi-asserted-by":"publisher","first-page":"595395","DOI":"10.3389\/fmolb.2020.595395","volume":"7","author":"Y Xi","year":"2021","unstructured":"Xi, Y., Jingying, D., Chenglong, L., Hong, Z., Rong, Z., Xiaodong, W., Chunsen, W., and Xiaobing, H. (2021). Epigenetic therapy promotes the ratio of Th1\/Th17 lineage to reverse immune evasion and treat leukemia relapse post-allogeneic stem cell transplantation in non-APL AML patients. Front Mol Biosci 7, 595395.","journal-title":"Front Mol Biosci"},{"key":"3436_CR217","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1038\/s41388-023-02874-5","volume":"42","author":"X Xie","year":"2023","unstructured":"Xie, X., Zhang, W., Zhou, X., Xu, B., Wang, H., Qiu, Y., Hu, Y., Guo, B., Ye, Z., Hu, L., et al. (2023). Low doses of IFN-\u03b3 maintain self-renewal of leukemia stem cells in acute myeloid leukemia. Oncogene 42, 3657\u20133669.","journal-title":"Oncogene"},{"key":"3436_CR218","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/leu.2016.287","volume":"31","author":"J Xin","year":"2017","unstructured":"Xin, J., You, D., Breslin, P., Li, J., Zhang, J., Wei, W., Cannova, J., Volk, A., Gutierrez, R., Xiao, Y., et al. (2017). Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1\/RIP3 pathway. Leukemia 31, 1154\u20131165.","journal-title":"Leukemia"},{"key":"3436_CR219","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2011.09.053","volume":"147","author":"S Yamazaki","year":"2011","unstructured":"Yamazaki, S., Ema, H., Karlsson, G., Yamaguchi, T., Miyoshi, H., Shioda, S., Taketo, M.M., Karlsson, S., Iwama, A., and Nakauchi, H. (2011). Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147, 1146\u20131158.","journal-title":"Cell"},{"key":"3436_CR220","doi-asserted-by":"publisher","first-page":"156672","DOI":"10.1016\/j.cyto.2024.156672","volume":"180","author":"M Yan","year":"2024","unstructured":"Yan, M., Chen, X., Ye, Q., Li, H., Zhang, L., and Wang, Y. (2024). IL-33-dependent NF-\u03baB activation inhibits apoptosis and drives chemoresistance in acute myeloid leukemia. Cytokine 180, 156672.","journal-title":"Cytokine"},{"key":"3436_CR221","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00277-017-3148-x","volume":"96","author":"D Yang","year":"2017","unstructured":"Yang, D., Zhang, X., Zhang, X., and Xu, Y. (2017). The progress and current status of immunotherapy in acute myeloid leukemia. Ann Hematol 96, 1965\u20131982.","journal-title":"Ann Hematol"},{"key":"3436_CR222","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12964-023-01367-y","volume":"22","author":"J Yang","year":"2024","unstructured":"Yang, J., Chen, J., Chang, J., Sun, X., Wei, Q., Cai, X., and Cao, P. (2024). IDH2\/R140Q mutation confers cytokine-independent proliferation of TF-1 cells by activating constitutive STAT3\/5 phosphorylation. Cell Commun Signal 22, 116.","journal-title":"Cell Commun Signal"},{"key":"3436_CR223","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3324\/haematol.2018.215269","volume":"104","author":"AL Young","year":"2019","unstructured":"Young, A.L., Tong, R.S., Birmann, B.M., and Druley, T.E. (2019). Clonal hematopoiesis and risk of acute myeloid leukemia. Haematologica 104, 2410\u20132417.","journal-title":"Haematologica"},{"key":"3436_CR224","doi-asserted-by":"publisher","first-page":"e0242809","DOI":"10.1371\/journal.pone.0242809","volume":"15","author":"B Yuan","year":"2020","unstructured":"Yuan, B., El Dana, F., Ly, S., Yan, Y., Ruvolo, V., Shpall, E.J., Konopleva, M., Andreeff, M., Battula, V.L., and Papaccio, G. (2020). Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-\u03b2-p38-ALDH2 pathway. PLoS One 15, e0242809.","journal-title":"PLoS One"},{"key":"3436_CR225","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13045-021-01133-y","volume":"14","author":"B Zhang","year":"2021","unstructured":"Zhang, B., Nguyen, L.X.T., Zhao, D., Frankhouser, D.E., Wang, H., Hoang, D.H., Qiao, J., Abundis, C., Brehove, M., Su, Y.L., et al. (2021). Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML. J Hematol Oncol 14, 122.","journal-title":"J Hematol Oncol"},{"key":"3436_CR226","doi-asserted-by":"publisher","first-page":"2105811","DOI":"10.1002\/advs.202105811","volume":"9","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Zhao, Q., Cang, H., Wang, Z., Hu, X., Pan, R., Yang, Y., and Chen, Y. (2022a). Acute myeloid leukemia cells educate mesenchymal stromal cells toward an adipogenic differentiation propensity with leukemia promotion capabilities. Adv Sci 9, 2105811.","journal-title":"Adv Sci"},{"key":"3436_CR227","doi-asserted-by":"publisher","first-page":"eaax5104","DOI":"10.1126\/scitranslmed.aax5104","volume":"12","author":"TY Zhang","year":"2020","unstructured":"Zhang, T.Y., Dutta, R., Benard, B., Zhao, F., Yin, R., and Majeti, R. (2020a). IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia. Sci Transl Med 12, eaax5104.","journal-title":"Sci Transl Med"},{"key":"3436_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-38315-2_1","volume":"1240","author":"W Zhang","year":"2020","unstructured":"Zhang, W., Borcherding, N., and Kolb, R. (2020b). IL-1 signaling in tumor microenvironment. Adv Exp Med Biol 1240, 1\u201323.","journal-title":"Adv Exp Med Biol"},{"key":"3436_CR229","doi-asserted-by":"publisher","first-page":"113112","DOI":"10.1016\/j.yexcr.2022.113112","volume":"415","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Guo, H., Zhang, Z., Lu, W., Zhu, J., and Shi, J. (2022b). IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia. Exp Cell Res 415, 113112.","journal-title":"Exp Cell Res"},{"key":"3436_CR230","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., and Li, Y. (2021). Inflammation and tumor progression: signaling pathways and targeted intervention. Sig Transduct Target Ther 6, 263.","journal-title":"Sig Transduct Target Ther"},{"key":"3436_CR231","doi-asserted-by":"publisher","first-page":"216767","DOI":"10.1016\/j.canlet.2024.216767","volume":"588","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y., Chen, W., Yu, J., Pei, S., Zhang, Q., Shi, J., Huang, H., and Zhao, Y. (2024). TP53 in MDS and AML: biological and clinical advances. Cancer Lett 588, 216767.","journal-title":"Cancer Lett"},{"key":"3436_CR232","doi-asserted-by":"publisher","first-page":"1078421","DOI":"10.3389\/fimmu.2022.1078421","volume":"13","author":"L Zheng","year":"2022","unstructured":"Zheng, L., Zhang, L., Guo, Y., Xu, X., Liu, Z., Yan, Z., and Fu, R. (2022). The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome. Front Immunol 13, 1078421.","journal-title":"Front Immunol"},{"key":"3436_CR233","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1182\/blood-2003-06-1969","volume":"103","author":"R Zheng","year":"2004","unstructured":"Zheng, R., Levis, M., Piloto, O., Brown, P., Baldwin, B.R., Gorin, N.C., Beran, M., Zhu, Z., Ludwig, D., Hicklin, D., et al. (2004). FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells. Blood 103, 267\u2013274.","journal-title":"Blood"},{"key":"3436_CR234","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/bjh.20066","volume":"206","author":"Z Zheng","year":"2025","unstructured":"Zheng, Z., Wang, W., Feng, M., Chen, X., Ren, F., and Hou, Y. (2025). The mechanism of EZH2\/H3K27me3 downregulating CXCL10 to affect CD8+ T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia. Br J Haematol 206, 1335\u20131349.","journal-title":"Br J Haematol"},{"key":"3436_CR235","doi-asserted-by":"publisher","first-page":"661939","DOI":"10.3389\/fimmu.2021.661939","volume":"12","author":"C Zhong","year":"2021","unstructured":"Zhong, C., Wang, R., Hua, M., Zhang, C., Han, F., Xu, M., Yang, X., Li, G., Hu, X., Sun, T., et al. (2021). NLRP3 inflammasome promotes the progression of acute myeloid leukemia via IL-1\u03b2 pathway. Front Immunol 12, 661939.","journal-title":"Front Immunol"},{"key":"3436_CR236","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1182\/blood-2015-01-624833","volume":"126","author":"X Zhou","year":"2015","unstructured":"Zhou, X., Zhou, S., Li, B., Li, Q., Gao, L., Li, D., Gong, Q., Zhu, L., Wang, J., Wang, N., et al. (2015). Transmembrane TNF-\u03b1 preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy. Blood 126, 1433\u20131442.","journal-title":"Blood"},{"key":"3436_CR237","doi-asserted-by":"publisher","first-page":"e1146","DOI":"10.1002\/cti2.1146","volume":"9","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z., Yan, F., and Liu, O. (2020). Interleukin (IL)-33: an orchestrator of immunity from host defence to tissue homeostasis. Clin Trans Imm 9, e1146.","journal-title":"Clin Trans Imm"},{"key":"3436_CR238","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.3389\/fimmu.2019.02879","volume":"10","author":"X Zhuang","year":"2019","unstructured":"Zhuang, X., Veltri, D.P., and Long, E.O. (2019). Genome-wide CRISPR screen reveals cancer cell resistance to NK cells induced by NK-derived IFN-\u03b3. Front Immunol 10, 2879.","journal-title":"Front Immunol"},{"key":"3436_CR239","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","volume":"130","author":"F Zink","year":"2017","unstructured":"Zink, F., Stacey, S.N., Norddahl, G.L., Frigge, M.L., Magnusson, O.T., Jonsdottir, I., Thorgeirsson, T.E., Sigurdsson, A., Gudjonsson, S.A., Gudmundsson, J., et al. (2017). Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 130, 742\u2013752.","journal-title":"Blood"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-026-3436-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-026-3436-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-026-3436-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:03:18Z","timestamp":1791820998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-026-3436-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":239,"alternative-id":["3436"],"URL":"https:\/\/doi.org\/10.1007\/s11427-026-3436-8","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}